advertisement

Oculus

List of abstracts related to

80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Khouri AS; Serle JB; Bacharach J; Usner DW; Lewis RA; Braswell P; Kopczynski CC; Heah T;
American Journal of Ophthalmology 2019; 204: 97-104

Listed by Classification


11.15 Other drugs in relation to glaucoma (1563 abstracts found)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Bilgic A
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Baneke AJ
Eye 2020; 34: 178-191 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Monsellato R
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Yu J
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhang F
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Elgin U
International Ophthalmology 2019; 0: (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Lommatzsch C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Bilgic A
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


85216 Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
Putera I
Case Reports in Ophthalmology 2020; 11: 85-91 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
McKay KM
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Chen YY
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Du J
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Wingard JB
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Heinz C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Chou P
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Sudhalkar A
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


85216 Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
Suryono AN
Case Reports in Ophthalmology 2020; 11: 85-91 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Patrie JT
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu K
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Kodjikian L
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Borkar DS
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Delzell DA
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Trovato E
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Qiu LX
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Sen E
International Ophthalmology 2019; 0: (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Aubry J
Eye 2020; 34: 178-191 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Qing GP
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Pan Z
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Sevgi DD
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Houlihan NV
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Rothaus K
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Ozdemir K
International Ophthalmology 2019; 0: (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Huang YF
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Turchetti P
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Prum BE
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Viswanathan AC
Eye 2020; 34: 178-191 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Chhablani J
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Rothaus K
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


85216 Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
Artini W
Case Reports in Ophthalmology 2020; 11: 85-91 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Trivedi M
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Netland PA
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Lin J
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Zhao BW
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Cao M
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Chien HJ
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Plant GT
Eye 2020; 34: 178-191 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Susarla G
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Forestiere M
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Ozdal P
International Ophthalmology 2019; 0: (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Koch JM
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Trivedi M
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Trivedi M
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Shildkrot YE
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Berker N
International Ophthalmology 2019; 0: (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Wu YC
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Trivedi M
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Papaliodis GN
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Gieser JP
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Wang H
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhou D
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Pistone A
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Lee CC
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Vasavada S
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Vasavada V
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Vasavada S
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu H
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
De Sio S
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Sobrin L
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Accetta L
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Huang LY
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Vasavada V
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Huang Y
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Srivastava S
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Duan X
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Vasavada S
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Chen HH
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Pacella F
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Vasavada S; Srivastava S; Bhojwani D; Sudhalkar A
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Pappelis K
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555 (IGR: 20-4)


82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Muhsen S
International Journal of Ophthalmology 2019; 12: 1567-1574 (IGR: 20-4)


82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Zhang Y
Journal of Ophthalmology 2019; 2019: 7419571 (IGR: 20-4)


82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Sadowsky AJ
Ocular Immunology and Inflammation 2019; 0: 1-5 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Rabina G
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82451 Trabeculectomy with Ologen® implant and bevacizumab
Glandorf K
Ophthalmologe 2019; 0: (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Lam J
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82583 A review of systemic medications that may modulate the risk of glaucoma
Wu A
Eye 2020; 34: 12-28 (IGR: 20-4)


82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Baker JC
Drugs and Aging 2019; 36: 991-997 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Groth SL
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Pecen PE
Ocular Immunology and Inflammation 2019; 0: 1-5 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Albeiruti E
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82583 A review of systemic medications that may modulate the risk of glaucoma
Khawaja AP
Eye 2020; 34: 12-28 (IGR: 20-4)


82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Loiselle AR
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Luttrell I
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Fintelmann R
Drugs and Aging 2019; 36: 991-997 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Barequet D
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Zhu S
Journal of Ophthalmology 2019; 2019: 7419571 (IGR: 20-4)


82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Pecen PE
Ocular Immunology and Inflammation 2019; 0: 1-5 (IGR: 20-4)


82451 Trabeculectomy with Ologen® implant and bevacizumab
Lommatzsch C
Ophthalmologe 2019; 0: (IGR: 20-4)


82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Compan J
International Journal of Ophthalmology 2019; 12: 1567-1574 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Nunez M
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Mimouni M
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82583 A review of systemic medications that may modulate the risk of glaucoma
Pasquale LR
Eye 2020; 34: 12-28 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Ding L
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Feinstein E
Ocular Immunology and Inflammation 2019; 0: 1-5 (IGR: 20-4)


82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Sharifi R
Drugs and Aging 2019; 36: 991-997 (IGR: 20-4)


82451 Trabeculectomy with Ologen® implant and bevacizumab
Heinz C
Ophthalmologe 2019; 0: (IGR: 20-4)


82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Lai T
International Journal of Ophthalmology 2019; 12: 1567-1574 (IGR: 20-4)


82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Xu X
Journal of Ophthalmology 2019; 2019: 7419571 (IGR: 20-4)


82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Visser S
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555 (IGR: 20-4)


82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Zuo L
Journal of Ophthalmology 2019; 2019: 7419571 (IGR: 20-4)


82451 Trabeculectomy with Ologen® implant and bevacizumab
Koch JM
Ophthalmologe 2019; 0: (IGR: 20-4)


82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Lee M
Drugs and Aging 2019; 36: 991-997 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Fajardo R
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Palestine AG
Ocular Immunology and Inflammation 2019; 0: 1-5 (IGR: 20-4)


82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Jansonius NM
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Kurtz S
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Kranemann C
International Journal of Ophthalmology 2019; 12: 1567-1574 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Rezaei K
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82583 A review of systemic medications that may modulate the risk of glaucoma
Stein JD
Eye 2020; 34: 12-28 (IGR: 20-4)


82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Birt C
International Journal of Ophthalmology 2019; 12: 1567-1574 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Shemesh G
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Sharpsten L
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Chao JR; Chee Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Loewen N
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Rosenblatt A
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Schuman JS
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Rosenfeld E
European Journal of Ophthalmology 2019; 0: 1120672119874682 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Olmos de Koo LC
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Goldberg JL
Ophthalmology 2019; 126: 1511-1516 (IGR: 20-4)


82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Wen JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494 (IGR: 20-4)


80484 Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab
Hiyama T
American journal of ophthalmology case reports 2019; 14: 1-4 (IGR: 20-3)


81054 Perioperative Anti-inflammatory Treatment in Glaucoma Surgery
Dietlein TS
Klinische Monatsblätter für Augenheilkunde 2019; 236: 647-652 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Okamoto M
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


80780 Medical management of glaucoma and interaction between glaucoma and systemic medications
Traustadottir VD
Laeknabladid 2019; 105: 163-169 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sakamoto E
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Saito H
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Brill D
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Parisi V
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


81150 Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
Schehlein EM
Drugs 2019; 79: 1031-1036 (IGR: 20-3)


81245 What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study
Shi L
BMC Ophthalmology 2019; 19: 128 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Wannamaker KW
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


81182 Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Cui QN
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1931-1939 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Filek R
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Rajesh B
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Moura-Coelho N
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


81393 The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
DE Oliveira BMR
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 116-120 (IGR: 20-3)


80576 Ocular dysfunctions and toxicities induced by antiepileptic medications: Types, pathogenic mechanisms, and treatment strategies
Hamed SA
Expert Review of Clinical Pharmacology 2019; 12: 309-328 (IGR: 20-3)


80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Ibrahim DG
Cell biochemistry and function 2019; 37: 113-124 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Elwehidy AS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Zeng R
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Kang JH
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Park MY
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Hooper P
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Oddone F
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Ishida W
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Boumenna T
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Bayoumi NHL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


81393 The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
Ferrari PV
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 116-120 (IGR: 20-3)


81182 Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Gray IN
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1931-1939 (IGR: 20-3)


81150 Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
Robin AL
Drugs 2019; 79: 1031-1036 (IGR: 20-3)


80484 Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab
Harada Y
American journal of ophthalmology case reports 2019; 14: 1-4 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Li YP
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Kim WJ
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Ko JA
Cell biochemistry and function 2019; 37: 113-124 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Bayoumi NHL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Nagahara M
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Kenny S
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Tavares Ferreira J
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


81054 Perioperative Anti-inflammatory Treatment in Glaucoma Surgery
Erb C
Klinische Monatsblätter für Augenheilkunde 2019; 236: 647-652 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Albert D
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Zarranz-Ventura J
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81245 What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study
Yang J
BMC Ophthalmology 2019; 19: 128 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Kagami S
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


80780 Medical management of glaucoma and interaction between glaucoma and systemic medications
Tryggvadottir EB
Laeknabladid 2019; 105: 163-169 (IGR: 20-3)


81245 What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study
Lin J
BMC Ophthalmology 2019; 19: 128 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Fields T
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Tajiri T
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


81182 Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Yu Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1931-1939 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Chen CL
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Lee E
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Fung AT
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Das R
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Bruxelas CP
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Stein JD
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


80780 Medical management of glaucoma and interaction between glaucoma and systemic medications
Gudmundsson A
Laeknabladid 2019; 105: 163-169 (IGR: 20-3)


80484 Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab
Kiuchi Y
American journal of ophthalmology case reports 2019; 14: 1-4 (IGR: 20-3)


80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Iwata W
Cell biochemistry and function 2019; 37: 113-124 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Mishima K
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Badawi AE
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


81054 Perioperative Anti-inflammatory Treatment in Glaucoma Surgery
Hoffmann E
Klinische Monatsblätter für Augenheilkunde 2019; 236: 647-652 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Sheidow TG
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Roberti G
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sumi T
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81393 The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
Herrerias BT
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 116-120 (IGR: 20-3)


80780 Medical management of glaucoma and interaction between glaucoma and systemic medications
Gottfredsdottir MS
Laeknabladid 2019; 105: 163-169 (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Dutra-Medeiros M
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Mataki N
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Okumichi H
Cell biochemistry and function 2019; 37: 113-124 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Gonder J
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Nakamura N
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Tanga L
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Kim C
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Hagras SM
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Mendlovitz A
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Huang YQ
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Mikkilineni S
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kishimoto T
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Khawaja A
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


81393 The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
Hirai FE
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 116-120 (IGR: 20-3)


81182 Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Vanderbeek BL
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1931-1939 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Busch C
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Crandall D
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Sahoo NK
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81453 Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
Abdelkader A
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 308-313 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Carnevale C
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Tada K
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Fukushima A
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Chakrabarti S
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


81393 The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
Gracitelli CPB
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 116-120 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Son SJ
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Carnevale C
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Comstock JM
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Rosner BA
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Kiuchi Y
Cell biochemistry and function 2019; 37: 113-124 (IGR: 20-3)


80780 Medical management of glaucoma and interaction between glaucoma and systemic medications
Olafsdottir OB
Laeknabladid 2019; 105: 163-169 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Lian H
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Fukunishi N
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Cunha JP
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fukuda K
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Yoon JS
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


81422 Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Hutnik CM
Clinical Ophthalmology 2019; 13: 1087-1096 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Ziccardi L
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Rodriguez-Valdes PJ
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Hu YZ
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Wiggs JL
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Nagahara K
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Chu ER
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80581 Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology
Pinto Proença R
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 1101-1117 (IGR: 20-3)


81288 Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use
Gao H
American journal of ophthalmology case reports 2019; 15: 100482 (IGR: 20-3)


80453 Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil
Araie M
Journal of Glaucoma 2019; 28: 289-293 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Sarao V
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81354 Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report
Yang JS
BMC Ophthalmology 2019; 19: 136 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Bahadorani S
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80969 Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Pasquale LR
JAMA ophthalmology 2019; 137: 756-765 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Yoneda T
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Kim W
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Manni G
Advances in Therapy 2019; 36: 987-996 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Mishra SK
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kuroiwa H
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Gresores NJ
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


81132 Association between use of benzodiazepines and occurrence of acute angle-closure glaucoma in the elderly: A population-based study
Namkoong K
Journal of psychosomatic research 2019; 122: 1-5 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Terao E
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Saatci AO
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Beck KD
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fujisawa Y
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Udaondo Mirete P
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Krambeer CJ; Kermany DS
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Querques G
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Nakakura S
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Diaz-Rohena R
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Jian K
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Farah ME; Lanzetta P
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Nolan DP
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Okumichi H
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Sohn JH
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Arevalo JF
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kiuchi Y
Scientific reports 2019; 9: 3755 (IGR: 20-3)


81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Singer MA
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)


80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fukushima A
Scientific reports 2019; 9: 3755 (IGR: 20-3)


80956 Safety of 6000 intravitreal dexamethasone implants
Kodjikian L; Chhablani J;
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)


80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Simsek T
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804 (IGR: 20-2)


80090 Rho kinase inhibitors for treatment of glaucoma
Mandell KJ
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)


79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Zhu S
Journal of Ophthalmology 2018; 2018: 7474086 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Zarranz-Ventura J
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Mostafaei A
International Ophthalmology 2019; 39: 2341-2351 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Adams CM
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Hoguet A
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Librando A
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


79570 Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
Addis VM
Clinical Ophthalmology 2018; 12: 2649-2657 (IGR: 20-2)


79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)


79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Kumar P
Journal of AAPOS 2019; 23: 55-57 (IGR: 20-2)


79393 Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
Duggan S
Drugs 2018; 78: 1925-1929 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kahook MY
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79438 ACUTE MYOPIA WITH ELEVATION OF INTRAOCULAR TENSION AS AN ADVERSE SIDE EFFECT OF ANTIDEPRESSANT MEDICATION
Hrčková L
?eska a Slovenska Oftalmologie 0; 74: 68-72 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Tanihara H
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Krishnamurthy R
Journal of AAPOS 2019; 23: 55-57 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Stacy R
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Sala-Puigdollers A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


80090 Rho kinase inhibitors for treatment of glaucoma
Kudelka MR
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Chen PP
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Serle JB
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Carlesimo SC
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Gaddie IB
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79438 ACUTE MYOPIA WITH ELEVATION OF INTRAOCULAR TENSION AS AN ADVERSE SIDE EFFECT OF ANTIDEPRESSANT MEDICATION
Mojžiš P
?eska a Slovenska Oftalmologie 0; 74: 68-72 (IGR: 20-2)


79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Wang D
Journal of Ophthalmology 2018; 2018: 7474086 (IGR: 20-2)


80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Bilgeç MD
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804 (IGR: 20-2)


79570 Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
Miller-Ellis E
Clinical Ophthalmology 2018; 12: 2649-2657 (IGR: 20-2)


79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Ko YC
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Kakuda T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Stacy R
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Taheri N
International Ophthalmology 2019; 39: 2341-2351 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Junk AK
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Chang YF
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)


79438 ACUTE MYOPIA WITH ELEVATION OF INTRAOCULAR TENSION AS AN ADVERSE SIDE EFFECT OF ANTIDEPRESSANT MEDICATION
Žiak P
?eska a Slovenska Oftalmologie 0; 74: 68-72 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Albanese G
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Bloomenstein M
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Han J
Journal of Ophthalmology 2018; 2018: 7474086 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Rangaswamy N
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Ghojazadeh M
International Ophthalmology 2019; 39: 2341-2351 (IGR: 20-2)


80090 Rho kinase inhibitors for treatment of glaucoma
Wirostko B
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Sano T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Bagga B
Journal of AAPOS 2019; 23: 55-57 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Velazquez-Villoria D
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Mah FS
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Bigelow C
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kim T
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Latifi A
International Ophthalmology 2019; 39: 2341-2351 (IGR: 20-2)


79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Senthil S
Journal of AAPOS 2019; 23: 55-57 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Kanno T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Figueras-Roca M
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Mruthyunjaya P
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Huang SH
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Albanese GM
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Moghaddam N
International Ophthalmology 2019; 39: 2341-2351 (IGR: 20-2)


79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Liu CJ
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Imada R
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Nouri-Mahdavi K
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Copete S
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Grosskreutz CL
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Migliorini R
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Raizman MB
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Radhakrishnan S
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Distefano L
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Pacella E
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Shingaki W
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Prasanna G
Pharmaceutical Research 2018; 36: 25 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Heah T
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Gunji R
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Ramirez-Davis N
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Boixadera A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Takusagawa HL
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kopczynski CC
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
García-Arumi J
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Chen TC
Ophthalmology 2019; 126: 611-622 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Adan A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Usner DW; Novack GD
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world

PLoS ONE 2019; 14: e0209997 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Pitha I
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Wiciński M
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


78822 Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
Zuo L
Journal of Ophthalmology 2018; 2018: 8965709 (IGR: 20-1)


78869 Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy - which provides the better outcome? A systematic review and meta-analysis
Almatlouh A
Acta Ophthalmologica 2019; 97: 146-157 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Vajaranant TS
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Valenzuela CV
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


78937
Leleu I
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


79086 Prospective pilot study comparing deep sclerectomy outcomes with a long-term and intense corticosteroid treatment versus a standard one
Lanzagorta-Aresti A
BMJ open ophthalmology 2018; 3: e000165 (IGR: 20-1)


78892 EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Sisk RA; Rusia D
Retina (Philadelphia, Pa.) 2019; 39: 1959-1964 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Liu JC
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Oglesby E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78937
Penaud B
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


79086 Prospective pilot study comparing deep sclerectomy outcomes with a long-term and intense corticosteroid treatment versus a standard one
Perez-Lopez M
BMJ open ophthalmology 2018; 3: e000165 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Kaluzny BJ
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


78869 Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy - which provides the better outcome? A systematic review and meta-analysis
Bach-Holm D
Acta Ophthalmologica 2019; 97: 146-157 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Ray RM
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78822 Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
Zhang J
Journal of Ophthalmology 2018; 2018: 8965709 (IGR: 20-1)


79086 Prospective pilot study comparing deep sclerectomy outcomes with a long-term and intense corticosteroid treatment versus a standard one
Davo-Cabrera JM
BMJ open ophthalmology 2018; 3: e000165 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Liberski S
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


78869 Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy - which provides the better outcome? A systematic review and meta-analysis
Kessel L
Acta Ophthalmologica 2019; 97: 146-157 (IGR: 20-1)


78892 EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Zamora BG
Retina (Philadelphia, Pa.) 2019; 39: 1959-1964 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Chow A
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78937
Blumen-Ohana E
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Vila PM
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


78822 Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
Xu X
Journal of Ophthalmology 2018; 2018: 8965709 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Pasquale LR
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Simon L
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


78937
Rodallec T
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Mares JA
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


79086 Prospective pilot study comparing deep sclerectomy outcomes with a long-term and intense corticosteroid treatment versus a standard one
Palacios-Pozo E
BMJ open ophthalmology 2018; 3: e000165 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Kimball E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78892 EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Kuley A
Retina (Philadelphia, Pa.) 2019; 39: 1959-1964 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Marczak D
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Kimball E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Ritch R
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Seredyka-Burduk M
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


78892 EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Toussaint BW
Retina (Philadelphia, Pa.) 2019; 39: 1959-1964 (IGR: 20-1)


78937
Adam R
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Pease ME
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Doering M
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Gower EW
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Schaub J
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78816 Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Pawlak-Osińska K
Survey of Ophthalmology 2019; 64: 185-194 (IGR: 20-1)


78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Lieu JEC
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Schaub J
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78937
Laplace O; Akesbi J
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Quigley H
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Haan MN
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78937
Nordmann JP
Journal Français d'Ophtalmologie 2018; 41: e329-e340 (IGR: 20-1)


78521 Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial
Jackson RD; Maki PM
American Journal of Ophthalmology 2018; 195: 110-120 (IGR: 20-1)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Wang HY
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Giudiceandrea A
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78246 A Novel Association between Oxybutynin Use and Bilateral Acute Angle Closure Glaucoma: A Case Report and Literature Review
Haddad A
Cureus 2018; 10: e2732 (IGR: 19-4)


78301 Short-Term Results of Sutureless Scleral Tunnel Trabeculectomy Using Adjunctive Topical Bevacizumab
Arish M
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 63-67 (IGR: 19-4)


78304 A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
Hidaka T
Case Reports in Ophthalmology 2018; 9: 401-404 (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Ganapathy PS
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Campos E
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


77334 Bilateral simultaneous acute angle closure attack triggered by an over-the-counter flu medication
Nicoară SD
International Ophthalmology 2018; 38: 1775-1778 (IGR: 19-4)


78099 Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery
Hilgert CR
Arquivos Brasileiros de Oftalmologia 2018; 81: 316-322 (IGR: 19-4)


78280 Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
Huang ST
Medicine 2018; 97: e11960 (IGR: 19-4)


78294 Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage
Song Y
Experimental and therapeutic medicine 2018; 16: 2506-2510 (IGR: 19-4)


78099 Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery
Hilgert AH
Arquivos Brasileiros de Oftalmologia 2018; 81: 316-322 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Tseng PT
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


78280 Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
Tian BS
Medicine 2018; 97: e11960 (IGR: 19-4)


78294 Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage
Song Q
Experimental and therapeutic medicine 2018; 16: 2506-2510 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Toro ME
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78304 A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
Chuman H
Case Reports in Ophthalmology 2018; 9: 401-404 (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Lowder CY
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Versura P
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78301 Short-Term Results of Sutureless Scleral Tunnel Trabeculectomy Using Adjunctive Topical Bevacizumab
Bagherzadeh O
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 63-67 (IGR: 19-4)


78246 A Novel Association between Oxybutynin Use and Bilateral Acute Angle Closure Glaucoma: A Case Report and Literature Review
Arwani M
Cureus 2018; 10: e2732 (IGR: 19-4)


77334 Bilateral simultaneous acute angle closure attack triggered by an over-the-counter flu medication
Damian I
International Ophthalmology 2018; 38: 1775-1778 (IGR: 19-4)


78304 A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
Nao-i N
Case Reports in Ophthalmology 2018; 9: 401-404 (IGR: 19-4)


78301 Short-Term Results of Sutureless Scleral Tunnel Trabeculectomy Using Adjunctive Topical Bevacizumab
Ahmadi SS
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 63-67 (IGR: 19-4)


78280 Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
Xiao O
Medicine 2018; 97: e11960 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Giannaccare G
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78099 Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery
Odashiro AN
Arquivos Brasileiros de Oftalmologia 2018; 81: 316-322 (IGR: 19-4)


78246 A Novel Association between Oxybutynin Use and Bilateral Acute Angle Closure Glaucoma: A Case Report and Literature Review
Sabbagh O
Cureus 2018; 10: e2732 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Stubbs B
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


78294 Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage
Li L
Experimental and therapeutic medicine 2018; 16: 2506-2510 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Scupola A
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Arepalli S
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Terzi A
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78294 Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage
Xu J
Experimental and therapeutic medicine 2018; 16: 2506-2510 (IGR: 19-4)


78301 Short-Term Results of Sutureless Scleral Tunnel Trabeculectomy Using Adjunctive Topical Bevacizumab
Sadeghi-Allahabadi J
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 63-67 (IGR: 19-4)


78099 Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery
Odashiro PRP
Arquivos Brasileiros de Oftalmologia 2018; 81: 316-322 (IGR: 19-4)


78280 Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
Yang YJ
Medicine 2018; 97: e11960 (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Baynes K
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Carvalho AF
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Caporossi A
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Li M
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Li DJ
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


78280 Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
Zhou SY
Medicine 2018; 97: e11960 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Nociti V
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78099 Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery
Paranhos A
Arquivos Brasileiros de Oftalmologia 2018; 81: 316-322 (IGR: 19-4)


78294 Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage
Liu X
Experimental and therapeutic medicine 2018; 16: 2506-2510 (IGR: 19-4)


78301 Short-Term Results of Sutureless Scleral Tunnel Trabeculectomy Using Adjunctive Topical Bevacizumab
Hassanzadeh S
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 63-67 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Bisti S; Di Marco S
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Chen TY
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Mirabella M
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Bena J; Srivastava SK
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Lin PY
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


77895 Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
Salgarello T
Ophthalmology and therapy 2018; 0: (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Buzzi M
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78254 The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Hsueh YT; Chen YZ; Chen YW; Chu CS
Journal of Affective Disorders 2018; 241: 63-70 (IGR: 19-4)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Katsanos A
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


76527 Netarsudil Ophthalmic Solution 0.02%: First Global Approval
Hoy SM
Drugs 2018; 78: 389-396 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Mahmoud A
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Miraftabi A
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Kim D
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76260 Anticlotting agents and the surgical management of glaucoma
Sozeri Y
Current Opinions in Ophthalmology 2018; 29: 185-189 (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Ono A
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


76850 Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor
Aydin R
Journal of Glaucoma 2018; 27: e113-e116 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Bower T
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang XC
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Zheng W
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


76227 Ginkgo biloba and its potential role in glaucoma
Kang JM
Current Opinions in Ophthalmology 2018; 29: 116-120 (IGR: 19-3)


77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Elgin U
International Ophthalmology 2019; 39: 1211-1217 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Lee A
Journal of Glaucoma 2018; 0: (IGR: 19-3)


76227 Ginkgo biloba and its potential role in glaucoma
Lin S
Current Opinions in Ophthalmology 2018; 29: 116-120 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Gorgoli K
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Nilforushan N
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Samek DA
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


76850 Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor
Tezel TH
Journal of Glaucoma 2018; 27: e113-e116 (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Pattamatta U
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76260 Anticlotting agents and the surgical management of glaucoma
Salim S
Current Opinions in Ophthalmology 2018; 29: 185-189 (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang T
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Sen E
International Ophthalmology 2019; 39: 1211-1217 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Abid F
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Hirooka K
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Greaves G
Journal of Glaucoma 2018; 0: (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Dryja TP
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Kelly E
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Wei Z
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Lee R
Journal of Glaucoma 2018; 0: (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Nakano Y
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Çolak S
International Ophthalmology 2019; 39: 1211-1217 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Mohammed A
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Ksiaa I
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Mohammed A
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Darghahi M
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Zhang Y
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Mikropoulos DG
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Alemzadeh SA
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang LL
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


77001 Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma
Yılmazbas P
International Ophthalmology 2019; 39: 1211-1217 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Zdravkova M
Journal of Glaucoma 2018; 0: (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Song D
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Zina S
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Arranz-Marquez E
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Healey PR
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Nitta E
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Kasner P
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Athanasopoulos GP
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Zhao RY
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Tian H
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Parsamanesh M
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Ahmad S
Journal of Glaucoma 2018; 0: (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Nishiyama A
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Athanasopoulos GP
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Carnt N
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Messaoud R
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Teus MA
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Camoriano D
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Tan W
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)


77026 Gene expression changes in the retina after systemic administration of aldosterone
Tsujikawa A
Japanese Journal of Ophthalmology 2018; 62: 499-507 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
McGovern K
Journal of Glaucoma 2018; 0: (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
Zoellner H
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Kahler KH
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


76528 Bilateral acute angle-closure glaucoma following tramadol subcutaneous administration
Khairallah M
BMC Ophthalmology 2018; 18: 50 (IGR: 19-3)


76771 Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Yadgari M
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Ghiuzeli C
Journal of Glaucoma 2018; 0: (IGR: 19-3)


76926 Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture
White AJR
Translational vision science & technology 2018; 7: 20 (IGR: 19-3)


76480 Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma
Khawaja AP
Ophthalmology 2018; 125: 984-993 (IGR: 19-3)


77143 Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma
Konstas AGP
Expert opinion on biological therapy 2018; 18: 719-724 (IGR: 19-3)


77150 Systemic medication usage in glaucoma patients
Kasner O
Canadian Journal of Ophthalmology 2018; 53: 242-245 (IGR: 19-3)


77258 Bilateral Angle Closure Following the Infusion of a Monoclonal Antibody to Treat Relapsing Multiple Myeloma
Hymowitz M
Journal of Glaucoma 2018; 0: (IGR: 19-3)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Whigham B
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75393 Effect of Continuous Systemic Administration of Esmolol on Intraocular Pressure During Surgery in a Sustained Steep Trendelenburg Position
Joo J
Journal of Glaucoma 2017; 26: 1068-1071 (IGR: 19-2)


75312 Anticoagulation in Glaucoma Surgery
Rahman SI
Seminars in Ophthalmology 2018; 33: 108-111 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Sánchez-López E
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75372 Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies
Bowen LL
Pharmacotherapy 2018; 38: 80-85 (IGR: 19-2)


75557 Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Bach A
International Journal of Ophthalmology 2017; 10: 1925-1927 (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Mahdjoubi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75448 The efficacy of preoperative posterior subtenon injection of triamcinolone acetonide in noninfectious uveitic patients with secondary glaucoma undergoing trabeculectomy
Keorochana N
Clinical Ophthalmology 2017; 11: 2057-2063 (IGR: 19-2)


75397 Acute Angle-closure Glaucoma Associated With Aripiprazole in the Setting of Plateau Iris Configuration
Shen E
Journal of Glaucoma 2018; 27: e40-e43 (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Najean M
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75448 The efficacy of preoperative posterior subtenon injection of triamcinolone acetonide in noninfectious uveitic patients with secondary glaucoma undergoing trabeculectomy
Kunasuntiwarakul S
Clinical Ophthalmology 2017; 11: 2057-2063 (IGR: 19-2)


75312 Anticoagulation in Glaucoma Surgery
Turalba A
Seminars in Ophthalmology 2018; 33: 108-111 (IGR: 19-2)


75397 Acute Angle-closure Glaucoma Associated With Aripiprazole in the Setting of Plateau Iris Configuration
Farukhi S
Journal of Glaucoma 2018; 27: e40-e43 (IGR: 19-2)


75393 Effect of Continuous Systemic Administration of Esmolol on Intraocular Pressure During Surgery in a Sustained Steep Trendelenburg Position
Kim J
Journal of Glaucoma 2017; 26: 1068-1071 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Oddone EZ
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Egea MA
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75372 Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies
McRae-Clark AL
Pharmacotherapy 2018; 38: 80-85 (IGR: 19-2)


75557 Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Filipowicz A
International Journal of Ophthalmology 2017; 10: 1925-1927 (IGR: 19-2)


75448 The efficacy of preoperative posterior subtenon injection of triamcinolone acetonide in noninfectious uveitic patients with secondary glaucoma undergoing trabeculectomy
Treesit I
Clinical Ophthalmology 2017; 11: 2057-2063 (IGR: 19-2)


75397 Acute Angle-closure Glaucoma Associated With Aripiprazole in the Setting of Plateau Iris Configuration
Schmutz M
Journal of Glaucoma 2018; 27: e40-e43 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Davis BM
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75393 Effect of Continuous Systemic Administration of Esmolol on Intraocular Pressure During Surgery in a Sustained Steep Trendelenburg Position
Lee J
Journal of Glaucoma 2017; 26: 1068-1071 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Woolson S
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75557 Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Gold AS
International Journal of Ophthalmology 2017; 10: 1925-1927 (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Lemaitre S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75557 Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Latiff A
International Journal of Ophthalmology 2017; 10: 1925-1927 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Coffman C
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75397 Acute Angle-closure Glaucoma Associated With Aripiprazole in the Setting of Plateau Iris Configuration
Mosaed S
Journal of Glaucoma 2018; 27: e40-e43 (IGR: 19-2)


75448 The efficacy of preoperative posterior subtenon injection of triamcinolone acetonide in noninfectious uveitic patients with secondary glaucoma undergoing trabeculectomy
Choontanom R
Clinical Ophthalmology 2017; 11: 2057-2063 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Guo L
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Dureau S; Dendale R
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Allingham RR
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75557 Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Murray TG
International Journal of Ophthalmology 2017; 10: 1925-1927 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Espina M
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Shieh C
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Levy C
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Silva AM; Calpena AC
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Rouic LL
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Muir KW
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Desjardins L
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Souto EMB; Ravindran N
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75263 Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
Cassoux N
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 411-420 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Ettcheto M; Camins A; García ML; Cordeiro MF
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Vo Kim S
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74574 Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
Ha JY
Korean Journal of Ophthalmology 2017; 31: 538-547 (IGR: 19-1)


74412 Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain
Loureiro M
Journal of Current Glaucoma Practice 2017; 11: 38-41 (IGR: 19-1)


74817 Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells
Cong L
Experimental and therapeutic medicine 2018; 15: 210-216 (IGR: 19-1)


74236 Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
Noor NA
Clinical Ophthalmology 2017; 11: 1417-1422 (IGR: 19-1)


74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Sudhalkar A
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)


74795 Ultrasound biomicroscopy in acetazolamide-induced myopic shift with appositional angle closure
Grigera JD
Arquivos Brasileiros de Oftalmologia 2017; 80: 327-329 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Maleškić S
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Sabers A
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74681 The Impact of Multiple Intravitreal Anti-VEGF Injections on Intraocular Pressure
Lamprakis I
Klinische Monatsblätter für Augenheilkunde 2017; 0: (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Lee WJ
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74281 Drug-induced Myopia and Bilateral Angle Closure Secondary to Zolmitriptan
Lee JTL
Journal of Glaucoma 2017; 26: 954-956 (IGR: 19-1)


74175 Use of phosphodiesterase inhibitors and prevalence of self-reported glaucoma in the United States
Chen SP
PLoS ONE 2017; 12: e0183388 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Sevgi DD
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74732 Isotretinoin-induced Angle Closure and Myopic Shift
Park YM
Journal of Glaucoma 2017; 26: e252-e254 (IGR: 19-1)


74566 Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma
Tailor R
Seminars in Ophthalmology 2017; 0: 1-7 (IGR: 19-1)


74321 The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
Bracha P
Survey of Ophthalmology 2018; 63: 281-295 (IGR: 19-1)


74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Kim YK
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Fajnkuchen F
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74732 Isotretinoin-induced Angle Closure and Myopic Shift
Lee TE
Journal of Glaucoma 2017; 26: e252-e254 (IGR: 19-1)


74321 The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
Moore NA
Survey of Ophthalmology 2018; 63: 281-295 (IGR: 19-1)


74574 Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
Lee TH
Korean Journal of Ophthalmology 2017; 31: 538-547 (IGR: 19-1)


74412 Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain
Matos R
Journal of Current Glaucoma Practice 2017; 11: 38-41 (IGR: 19-1)


74817 Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells
Fu S
Experimental and therapeutic medicine 2018; 15: 210-216 (IGR: 19-1)


74236 Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
Mustafa S
Clinical Ophthalmology 2017; 11: 1417-1422 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Battino D
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74795 Ultrasound biomicroscopy in acetazolamide-induced myopic shift with appositional angle closure
Grigera ED
Arquivos Brasileiros de Oftalmologia 2017; 80: 327-329 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Davoudi S
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74566 Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma
Kinsella MT
Seminars in Ophthalmology 2017; 0: 1-7 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Kusturica J
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74281 Drug-induced Myopia and Bilateral Angle Closure Secondary to Zolmitriptan
Skalicky SE
Journal of Glaucoma 2017; 26: 954-956 (IGR: 19-1)


74175 Use of phosphodiesterase inhibitors and prevalence of self-reported glaucoma in the United States
Singh K
PLoS ONE 2017; 12: e0183388 (IGR: 19-1)


74681 The Impact of Multiple Intravitreal Anti-VEGF Injections on Intraocular Pressure
Todorova MG
Klinische Monatsblätter für Augenheilkunde 2017; 0: (IGR: 19-1)


74566 Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma
Clarke JC
Seminars in Ophthalmology 2017; 0: 1-7 (IGR: 19-1)


74817 Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells
Zhang J
Experimental and therapeutic medicine 2018; 15: 210-216 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Bonizzoni E
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Gušić E
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74175 Use of phosphodiesterase inhibitors and prevalence of self-reported glaucoma in the United States
Lin SC
PLoS ONE 2017; 12: e0183388 (IGR: 19-1)


74281 Drug-induced Myopia and Bilateral Angle Closure Secondary to Zolmitriptan
Lin ML
Journal of Glaucoma 2017; 26: 954-956 (IGR: 19-1)


74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Chhablani J
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)


74321 The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
Ciulla TA
Survey of Ophthalmology 2018; 63: 281-295 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Talcott KE
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74574 Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
Sung MS
Korean Journal of Ophthalmology 2017; 31: 538-547 (IGR: 19-1)


74681 The Impact of Multiple Intravitreal Anti-VEGF Injections on Intraocular Pressure
Grüb M
Klinische Monatsblätter für Augenheilkunde 2017; 0: (IGR: 19-1)


74236 Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
Artini W
Clinical Ophthalmology 2017; 11: 1417-1422 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Kim YW
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74412 Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain
Sepulveda P
Journal of Current Glaucoma Practice 2017; 11: 38-41 (IGR: 19-1)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Sarda V
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Cho H
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74321 The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
WuDunn D
Survey of Ophthalmology 2018; 63: 281-295 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Rakanović-Todić M
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Jeoung JW
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74681 The Impact of Multiple Intravitreal Anti-VEGF Injections on Intraocular Pressure
Schlote T
Klinische Monatsblätter für Augenheilkunde 2017; 0: (IGR: 19-1)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Qu-Knafo L
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74412 Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain
Meira D
Journal of Current Glaucoma Practice 2017; 11: 38-41 (IGR: 19-1)


74817 Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells
Zhao J
Experimental and therapeutic medicine 2018; 15: 210-216 (IGR: 19-1)


74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Bhojwani D
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Craig J
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74574 Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
Park SW
Korean Journal of Ophthalmology 2017; 31: 538-547 (IGR: 19-1)


74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Vasavada A
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Bodaghi B
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Kim SH
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74321 The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
Cantor LB
Survey of Ophthalmology 2018; 63: 281-295 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Šečić D
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Guo R
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74817 Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells
Zhang Y
Experimental and therapeutic medicine 2018; 15: 210-216 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Lindhout D
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Lobo AM
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Burnazović-Ristić L
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74205 Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Giocanti-Aurégan A
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 2165-2171 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Perucca E
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Heo JW
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Papaliodis GN
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Thomas SV
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Yu HG
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74841 Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study
Kulo A
Acta medica academica 2017; 46: 116-123 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Turalba A
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Tomson T
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74435 Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition
Park KH
Journal of Glaucoma 2017; 26: 980-986 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Sobrin L
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


74644 Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy
Vajda F
Epilepsy research 2017; 137: 159-162 (IGR: 19-1)


74797 A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma
Shen LQ
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2017; 23: 63-70 (IGR: 19-1)


72814 Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
Sun JT
International Journal of Ophthalmology 2017; 10: 400-405 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Höhn R
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72629 A cute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report
Jeong S
BMC Ophthalmology 2017; 17: 25 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Shi H
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Wen JC
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Antoun J
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72658 Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Eadie BD
JAMA ophthalmology 2017; 135: 363-368 (IGR: 18-4)


72814 Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
Liang HJ
International Journal of Ophthalmology 2017; 10: 400-405 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Willermain F
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Reina-Torres E
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Wang H
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Mirshahi A
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72629 A cute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report
Sagong M
BMC Ophthalmology 2017; 17: 25 (IGR: 18-4)


72658 Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Etminan M
JAMA ophthalmology 2017; 135: 363-368 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Sherwood JM
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Nickels S
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Fu S
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72658 Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Carleton BC
JAMA ophthalmology 2017; 135: 363-368 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Makhoul D
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72814 Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
An M
International Journal of Ophthalmology 2017; 10: 400-405 (IGR: 18-4)


72629 A cute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report
Chang W
BMC Ophthalmology 2017; 17: 25 (IGR: 18-4)


72814 Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
Wang DB
International Journal of Ophthalmology 2017; 10: 400-405 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Xu K
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Motulsky E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Challa P
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72658 Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Maberley DA
JAMA ophthalmology 2017; 135: 363-368 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Schulz A
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72658 Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Mikelberg FS
JAMA ophthalmology 2017; 135: 363-368 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Liu KC
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Wild PS
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Caspers L
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Zhang X
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Blettner M
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Li G
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Xiao Y
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Relvas LJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318 (IGR: 18-4)


72608 Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy
Ye W
Investigative Ophthalmology and Visual Science 2017; 58: 1478-1486 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Chang JY
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Pfeiffer N
British Journal of Ophthalmology 2017; 101: 1633-1637 (IGR: 18-4)


72752 Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Cousins SW; Schuman SG; Mettu PS; Stamer WD; Overby DR; Allingham RR
Investigative Ophthalmology and Visual Science 2017; 58: 1893-1898 (IGR: 18-4)


71550 Can Anti-VEGF Injections Cause Glaucoma or Ocular Hypertension?
Lanzl I
Klinische Monatsblätter für Augenheilkunde 2017; 234: 191-193 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Braun R
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71332 Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma
Talwar N
JAMA ophthalmology 2017; 135: 263-267 (IGR: 18-3)


71553 Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
Zhang L
Cochrane Database of Systematic Reviews 2017; 2: CD010746 (IGR: 18-3)


71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Saleh R
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824 (IGR: 18-3)


71466 Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Faiq MA
Current Molecular Medicine 2017; 0: (IGR: 18-3)


71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Inoue K
International Ophthalmology 2018; 38: 93-98 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Panchal SS
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71019 Randomized Prospective Study of the Use of Anti-Inflammatory Drops After Selective Laser Trabeculoplasty
De Keyser M
Journal of Glaucoma 2017; 26: e22-e29 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Ho H
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71556 Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension
Kaufman PL
Expert Opinion in Pharmacotherapy 2017; 18: 433-444 (IGR: 18-3)


71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Kola M
International Ophthalmology 2018; 38: 385-388 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Inazaki H
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Chen VC
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71334 Impact of Drugs on Glaucoma and Intraocular Pressure
Schlote T
Klinische Monatsblätter für Augenheilkunde 2017; 234: 179-184 (IGR: 18-3)


71224 Rho kinase inhibitors: a patent review (2014 - 2016)
Defert O
Expert Opinion on Therapeutic Patents 2017; 0: 1-9 (IGR: 18-3)


71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Karpe A
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Patidar RK
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Hacıoğlu D
International Ophthalmology 2018; 38: 385-388 (IGR: 18-3)


71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Okayama R
International Ophthalmology 2018; 38: 93-98 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Ng MH
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Kobayashi S
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71466 Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Dada T
Current Molecular Medicine 2017; 0: (IGR: 18-3)


71224 Rho kinase inhibitors: a patent review (2014 - 2016)
Boland S
Expert Opinion on Therapeutic Patents 2017; 0: 1-9 (IGR: 18-3)


71332 Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma
Musch DC
JAMA ophthalmology 2017; 135: 263-267 (IGR: 18-3)


71019 Randomized Prospective Study of the Use of Anti-Inflammatory Drops After Selective Laser Trabeculoplasty
De Belder M
Journal of Glaucoma 2017; 26: e22-e29 (IGR: 18-3)


71550 Can Anti-VEGF Injections Cause Glaucoma or Ocular Hypertension?
Kotliar K
Klinische Monatsblätter für Augenheilkunde 2017; 234: 191-193 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Holler E
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Shi Y
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71553 Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
Weizer JS
Cochrane Database of Systematic Reviews 2017; 2: CD010746 (IGR: 18-3)


71019 Randomized Prospective Study of the Use of Anti-Inflammatory Drops After Selective Laser Trabeculoplasty
De Groot V
Journal of Glaucoma 2017; 26: e22-e29 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Chua J
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Erdöl H
International Ophthalmology 2018; 38: 385-388 (IGR: 18-3)


71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Shiokawa M
International Ophthalmology 2018; 38: 93-98 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Wolff D
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Chiu WC
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71332 Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma
Stein JD
JAMA ophthalmology 2017; 135: 263-267 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Anzai Y
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71553 Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
Musch DC
Cochrane Database of Systematic Reviews 2017; 2: CD010746 (IGR: 18-3)


71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Zinkernagel MS
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Jha AB
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
McIntyre RS
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Ishida K
International Ophthalmology 2018; 38: 93-98 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Satoh H
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Tham YC
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Helbig H
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Allam AA
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Munk MR
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824 (IGR: 18-3)


71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Türk A
International Ophthalmology 2018; 38: 385-388 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Lim SH
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Blecha C
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Ajarem J
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Lee Y
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Tomita G
International Ophthalmology 2018; 38: 93-98 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Sato S
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Butani SB
Journal of Ophthalmology 2017; 2017: 1468716 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Lin TY
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Inoue M
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71614 Bilateral ciliary body oedema under treatment with ciclosporine
Dietrich-Ntoukas T
Ophthalmologe 2018; 115: 55-58 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Aung T
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Yamane S
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Wong TY
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Weng JC
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Kadonosono K
Journal of Glaucoma 2017; 26: 96-100 (IGR: 18-3)


71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheng CY
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)


71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Chen PC; Hsu CY
PLoS ONE 2017; 12: e0173005 (IGR: 18-3)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Kabesha TB
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


69789 Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis
Chang IT
Journal of Glaucoma 2016; 25: 842-846 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Hennein L
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70710 Intraocular Pressure after Intravitreal Triesence Injection
Atchison EA
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 18-2)


70451 Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial
Yazdani S
European Journal of Ophthalmology 2016; 0: 0 (IGR: 18-2)


70108 Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
Spratt A
Journal of Glaucoma 2017; 26: e160-e162 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Sun Y
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Andrés-Guerrero V
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
Fischer CV
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70806 Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Zhou Y
Scientific reports 2016; 6: 39301 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Reis GM
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Malclès A
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Horwitz A
Hypertension 2017; 69: 202-210 (IGR: 18-2)


70783 Combined Acute Haemolytic and Secondary Angle Closure Glaucoma following Spontaneous Intraocular Haemorrhages in a Patient on Warfarin
Andreatta W
Case Reports in Ophthalmology 2016; 7: 233-238 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Milla E
International Ophthalmology 2016; 0: (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Alagöz N
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70108 Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
Blieden LS
Journal of Glaucoma 2017; 26: e160-e162 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Alagöz C
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Grigg J
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Kabesha D
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


70783 Combined Acute Haemolytic and Secondary Angle Closure Glaucoma following Spontaneous Intraocular Haemorrhages in a Patient on Warfarin
Boukouvala S
Case Reports in Ophthalmology 2016; 7: 233-238 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Stirbu O
International Ophthalmology 2016; 0: (IGR: 18-2)


70451 Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial
Doozandeh A
European Journal of Ophthalmology 2016; 0: 0 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Liang Y
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70710 Intraocular Pressure after Intravitreal Triesence Injection
Bakri SJ
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 18-2)


69789 Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis
Gupta D
Journal of Glaucoma 2016; 25: 842-846 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Dot C
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Hou J
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Klemp M
Hypertension 2017; 69: 202-210 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Perucho-González L
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
Mans V
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70806 Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Zhou M
Scientific reports 2016; 6: 39301 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
García-Feijoo J
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70783 Combined Acute Haemolytic and Secondary Angle Closure Glaucoma following Spontaneous Intraocular Haemorrhages in a Patient on Warfarin
Bansal A
Case Reports in Ophthalmology 2016; 7: 233-238 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Stewart JM
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Yıldırım Y
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70451 Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial
Pakravan M
European Journal of Ophthalmology 2016; 0: 0 (IGR: 18-2)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Maloba V
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Voirin N
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Franco IJ
International Ophthalmology 2016; 0: (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Zhou P
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Jeppesen J
Hypertension 2017; 69: 202-210 (IGR: 18-2)


69789 Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis
Slabaugh MA
Journal of Glaucoma 2016; 25: 842-846 (IGR: 18-2)


70806 Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Xia S
Scientific reports 2016; 6: 39301 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
Horn M
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70108 Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
Dubovy SR
Journal of Glaucoma 2017; 26: e160-e162 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Chua B; Lee A
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Morales-Fernández L
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70451 Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial
Ownagh V
European Journal of Ophthalmology 2016; 0: 0 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Tsai JC
Hypertension 2017; 69: 202-210 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Vié AL
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70806 Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Jing Q
Scientific reports 2016; 6: 39301 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Lowry EA
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70108 Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
Berrocal A
Journal of Glaucoma 2017; 26: e160-e162 (IGR: 18-2)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Mwamba C
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
Naxer S
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Yeşilkaya C
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Wu H
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


69789 Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis
Vemulakonda GA
Journal of Glaucoma 2016; 25: 842-846 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Hernández SJ
International Ophthalmology 2016; 0: (IGR: 18-2)


69789 Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis
Chen PP
Journal of Glaucoma 2016; 25: 842-846 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Torp-Pedersen C
Hypertension 2017; 69: 202-210 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
Klettner A
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70806 Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Gao L
Scientific reports 2016; 6: 39301 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Hou X
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Saenz-Francés F
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Jiang Z
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Rios J
International Ophthalmology 2016; 0: (IGR: 18-2)


70108 Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
Lee RK
Journal of Glaucoma 2017; 26: e160-e162 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Lim R
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Chenge B
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


70451 Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial
Yaseri M
European Journal of Ophthalmology 2016; 0: 0 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Agard É
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Altan Ç
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70681 Antihypertensive Medication Postpones the Onset of Glaucoma: Evidence From a Nationwide Study
Kolko M
Hypertension 2017; 69: 202-210 (IGR: 18-2)


70249 The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition
van Oterendorp C
Investigative Ophthalmology and Visual Science 2016; 57: 4970-4977 (IGR: 18-2)


70410 Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification
Duch S
International Ophthalmology 2016; 0: (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Bozkurt E
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Ren Z
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Herrero-Vanrell R
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Higgins R
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Bellocq D
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70610 Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)
Mukalay A
Journal Français d'Ophtalmologie 2017; 40: 17-21 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Enanoria WT
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Martins A
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Júlvez LP
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Denis P
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Han Y
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Şatana B
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Li X; Zhao M
BMC Ophthalmology 2016; 16: 150 (IGR: 18-2)


70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Goldberg I
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Başarır B
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Llorens VP
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Clement CI
Journal of Current Glaucoma Practice 2017; 11: 3-7 (IGR: 18-2)


70869 The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
Taşkapılı M
Turkish journal of ophthalmology 2016; 46: 169-174 (IGR: 18-2)


70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Martínez-de-la-Casa JM; Konstas AP
Advances in Therapy 2017; 34: 378-395 (IGR: 18-2)


69037 Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications
Liu L
BMC Ophthalmology 2016; 16: 65 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Takkar B
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


68870 Delivery of steroids into the eye for the treatment of macular edema
Hadayer A
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Kaushik J
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


69030 Topiramate associated non-glaucomatous visual field defects
Haque S
Journal of Clinical Neuroscience 2016; 31: 210-213 (IGR: 18-1)


68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Foxton R
Cell Death and Disease 2016; 7: e2212 (IGR: 18-1)


68894 Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma
Chen HY
The Journal of clinical psychiatry 2016; 77: e692-e696 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Goñi FJ
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69232 Association between self-reported bupropion use and glaucoma: a population-based study
Masís M
British Journal of Ophthalmology 2017; 101: 525-529 (IGR: 18-1)


69115 Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
Durai I
Case reports in ophthalmological medicine 2016; 2016: 3713818 (IGR: 18-1)


69146 Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Shen X
Journal of Ophthalmology 2016; 2016: 4108490 (IGR: 18-1)


68870 Delivery of steroids into the eye for the treatment of macular edema
Schaal S
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)


69232 Association between self-reported bupropion use and glaucoma: a population-based study
Kakigi C
British Journal of Ophthalmology 2017; 101: 525-529 (IGR: 18-1)


69030 Topiramate associated non-glaucomatous visual field defects
Shaffi M
Journal of Clinical Neuroscience 2016; 31: 210-213 (IGR: 18-1)


69146 Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Chen Y
Journal of Ophthalmology 2016; 2016: 4108490 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Stalmans I
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69115 Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
Mohan Dhavalikar M
Case reports in ophthalmological medicine 2016; 2016: 3713818 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Chandra P
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


69037 Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications
Xu Y
BMC Ophthalmology 2016; 16: 65 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Parihar JK
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Osborne A
Cell Death and Disease 2016; 7: e2212 (IGR: 18-1)


68894 Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma
Lin CL
The Journal of clinical psychiatry 2016; 77: e692-e696 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Shah R
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


69115 Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
Anand CP
Case reports in ophthalmological medicine 2016; 2016: 3713818 (IGR: 18-1)


69037 Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications
Huang Z
BMC Ophthalmology 2016; 16: 65 (IGR: 18-1)


69232 Association between self-reported bupropion use and glaucoma: a population-based study
Singh K
British Journal of Ophthalmology 2017; 101: 525-529 (IGR: 18-1)


68894 Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma
Lai SW
The Journal of clinical psychiatry 2016; 77: e692-e696 (IGR: 18-1)


69146 Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Wang Y
Journal of Ophthalmology 2016; 2016: 4108490 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Jain VK
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Martin KR
Cell Death and Disease 2016; 7: e2212 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Denis P
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69030 Topiramate associated non-glaucomatous visual field defects
Tang KC
Journal of Clinical Neuroscience 2016; 31: 210-213 (IGR: 18-1)


68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Ng YS
Cell Death and Disease 2016; 7: e2212 (IGR: 18-1)


68894 Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma
Kao CH
The Journal of clinical psychiatry 2016; 77: e692-e696 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Gupta S
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Bhatia I
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Nordmann JP
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69037 Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications
Wang X
BMC Ophthalmology 2016; 16: 65 (IGR: 18-1)


69115 Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
Ganesh V
Case reports in ophthalmological medicine 2016; 2016: 3713818 (IGR: 18-1)


69232 Association between self-reported bupropion use and glaucoma: a population-based study
Lin S
British Journal of Ophthalmology 2017; 101: 525-529 (IGR: 18-1)


69146 Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Yang L
Journal of Ophthalmology 2016; 2016: 4108490 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Nath P
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


69146 Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Zhong Y
Journal of Ophthalmology 2016; 2016: 4108490 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Taylor S
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Roy S
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Shima DT
Cell Death and Disease 2016; 7: e2212 (IGR: 18-1)


69115 Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
Krishnadas R
Case reports in ophthalmological medicine 2016; 2016: 3713818 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Diestelhorst M
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


69254 Effect of Intravenous Mannitol on Intraocular Pressure in Vitrectomized Silicone-Oil-Filled Eyes
Sihota R
Seminars in Ophthalmology 2016; 0: 1-4 (IGR: 18-1)


69096 Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study
Durgapal P; Ram J
Current Eye Research 2016; 0: 1-8 (IGR: 18-1)


68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Figueiredo AR; Garway-Heath DF
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)


66801 Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome
Jin SW
Japanese Journal of Ophthalmology 2016; 60: 150-155 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Cinik R
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


66816 INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Seidman CJ
Retinal cases & brief reports 2017; 11: 47-50 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Turno-Kręcicka A
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Foss AJ
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


66928 Current management of glaucoma and vascular occlusive disease
Aref AA
Current Opinions in Ophthalmology 2016; 27: 140-145 (IGR: 17-4)


67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Golakiya HN
Current drug safety 2016; 0: (IGR: 17-4)


67154 The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Liu X
Medicine 2016; 95: e3223 (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Konieczka K
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


67431 The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis
McCann P
Investigative Ophthalmology and Visual Science 2016; 57: 2729-2748 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Wang YE
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Okumura N
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


67287 Evaluation of Ex-PRESS mini glaucoma shunt implantation with preoperative intracameral bevacizumab injection in refractory neovascular glaucoma
Guven Yilmaz S
European Journal of Ophthalmology 2016; 0: 0 (IGR: 17-4)


67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Hirapara HN
Current drug safety 2016; 0: (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Todorova MG
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Okazaki Y
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


67431 The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis
Hogg RE
Investigative Ophthalmology and Visual Science 2016; 57: 2729-2748 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Kakigi C
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


66816 INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Finger PT
Retinal cases & brief reports 2017; 11: 47-50 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Scott LJ
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


67287 Evaluation of Ex-PRESS mini glaucoma shunt implantation with preoperative intracameral bevacizumab injection in refractory neovascular glaucoma
Yildirim S
European Journal of Ophthalmology 2016; 0: 0 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Yüksel N
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Grzybowski A
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


66801 Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome
Min JS
Japanese Journal of Ophthalmology 2016; 60: 150-155 (IGR: 17-4)


67154 The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Du L
Medicine 2016; 95: e3223 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Barbosa D
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


67154 The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Li N
Medicine 2016; 95: e3223 (IGR: 17-4)


67287 Evaluation of Ex-PRESS mini glaucoma shunt implantation with preoperative intracameral bevacizumab injection in refractory neovascular glaucoma
Degirmenci C
European Journal of Ophthalmology 2016; 0: 0 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Pirhan D
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Misiuk-Hojło M
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Parmar SJ
Current drug safety 2016; 0: (IGR: 17-4)


66816 INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Silverman JS
Retinal cases & brief reports 2017; 11: 47-50 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Rogers CA
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


67431 The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis
Fallis R
Investigative Ophthalmology and Visual Science 2016; 57: 2729-2748 (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Bojinova RI
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Inoue R
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Reeves BC
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Binggeli T
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


67431 The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis
Azuara-Blanco A
Investigative Ophthalmology and Visual Science 2016; 57: 2729-2748 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Aslan MŞ
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


67287 Evaluation of Ex-PRESS mini glaucoma shunt implantation with preoperative intracameral bevacizumab injection in refractory neovascular glaucoma
Ates H
European Journal of Ophthalmology 2016; 0: 0 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Patryn E
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Kakutani K
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Naik VN
Current drug safety 2016; 0: (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Porco T
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


66816 INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Oratz R
Retinal cases & brief reports 2017; 11: 47-50 (IGR: 17-4)


67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Tripathi CB
Current drug safety 2016; 0: (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Nakano S
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Chen R
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Chackathayil TN
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Czajor K
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Subaşı C
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Ghanchi F
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


67498 The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model
Karaöz E
Current Eye Research 2016; 0: 1-9 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Wang S
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


66753 Ocular changes induced by drugs commonly used in dermatology
Nita M
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Kinoshita S
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Gibson J
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


67136 Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome
Flammer J
Klinische Monatsblätter für Augenheilkunde 2016; 233: 387-390 (IGR: 17-4)


66667 Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing
Koizumi N
Investigative Ophthalmology and Visual Science 2016; 57: 1284-1292 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Li Y
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


67563 Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Chakravarthy U;
British Journal of Ophthalmology 2016; 100: 1662-1667 (IGR: 17-4)


66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Singh K; Pasquale LR; Lin SC
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Ozkaya A
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66558 The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness
Omay E
International Ophthalmology 2016; 36: 665-670 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Tang M
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Olmos LC
Eye 2016; 30: 463-472 (IGR: 17-3)


66566 Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
Cheng JW
Cochrane Database of Systematic Reviews 2016; 1: CD009782 (IGR: 17-3)


65826 Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma
Ishibashi S
Sangyo Ika Daigaku Zasshi 2015; 37: 299-304 (IGR: 17-3)


66259 Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
Zhou M
PLoS ONE 2016; 11: e0146993 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Fu Y
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66558 The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness
Elgin U
International Ophthalmology 2016; 36: 665-670 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Sayed MS
Eye 2016; 30: 463-472 (IGR: 17-3)


66566 Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
Cheng SW
Cochrane Database of Systematic Reviews 2016; 1: CD009782 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Alagoz C
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


65826 Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma
Kondo H
Sangyo Ika Daigaku Zasshi 2015; 37: 299-304 (IGR: 17-3)


66259 Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
Wang J; Wang W
PLoS ONE 2016; 11: e0146993 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Moraczewski AL
Eye 2016; 30: 463-472 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Alagoz N
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66558 The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness
Sen E
International Ophthalmology 2016; 36: 665-670 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Wang Y
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66566 Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
Wei RL; Lu GC
Cochrane Database of Systematic Reviews 2016; 1: CD009782 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Gedde SJ
Eye 2016; 30: 463-472 (IGR: 17-3)


66558 The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness
Yilmazbas P
International Ophthalmology 2016; 36: 665-670 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Zheng Z
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Gunes H
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66259 Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
Huang W
PLoS ONE 2016; 11: e0146993 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Fan Y
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66259 Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
Ding X
PLoS ONE 2016; 11: e0146993 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Yilmaz I
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Rosenfeld PJ
Eye 2016; 30: 463-472 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Perente I
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66259 Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
Zhang X
PLoS ONE 2016; 11: e0146993 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Shi W
Eye 2016; 30: 463-472 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Sun X
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Feuer WJ
Eye 2016; 30: 463-472 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Yazici AT
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66594 Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
Xu X
BMC Ophthalmology 2016; 16: 7 (IGR: 17-3)


66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Taskapili M
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)


66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Lee RK
Eye 2016; 30: 463-472 (IGR: 17-3)


61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Reid GA
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)


61667 Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
Paula JS
Arquivos Brasileiros de Oftalmologia 2015; 78: 194-196 (IGR: 17-1)


61111 Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery
Van Bergen T
Acta Ophthalmologica 2015; 93: 667-678 (IGR: 17-1)


61818 The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome
Fang L
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 935-939 (IGR: 17-1)


61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Ozkurt YB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)


61074 Aflibercept for the treatment of neovascular glaucoma
Soohoo JR
Clinical and Experimental Ophthalmology 2015; 43: 803-807 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Guigou S
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Lam WC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61673 Application of anti-VEGF agents in treatment of neovascular glaucoma and anti-scarring in filtering surgery
Jia X
Chinese Journal of Ophthalmology 2015; 51: 314-318 (IGR: 17-1)


61060 Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty
Champagne S
Journal Français d'Ophtalmologie 2015; 38: 588-594 (IGR: 17-1)


61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Kabesha TB
Journal Français d'Ophtalmologie 2015; 38: 414-420 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Kim M
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61500 The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder
Larrañaga-Fragoso P
Journal of AAPOS 2015; 19: 322-326 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Ohira S
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Dedania VS
Retina (Philadelphia, Pa.) 2015; 35: 841-858 (IGR: 17-1)


61714 Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis
Murphy RM
Journal of Glaucoma 2016; 25: e99-e105 (IGR: 17-1)


61664 Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
Li XJ
Chinese Medical Journal 2015; 128: 2078-2083 (IGR: 17-1)


61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Bakri SJ
Retina (Philadelphia, Pa.) 2015; 35: 841-858 (IGR: 17-1)


61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Akkaya S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)


61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Glacet-Bernard A
Journal Français d'Ophtalmologie 2015; 38: 414-420 (IGR: 17-1)


61714 Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis
Bakir B
Journal of Glaucoma 2016; 25: e99-e105 (IGR: 17-1)


61500 The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder
Noval S
Journal of AAPOS 2015; 19: 322-326 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Inoue T
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Lee C
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61664 Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
Yang XP
Chinese Medical Journal 2015; 128: 2078-2083 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Albiani DA
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61667 Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
Secches DJ
Arquivos Brasileiros de Oftalmologia 2015; 78: 194-196 (IGR: 17-1)


61060 Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty
Anctil JL
Journal Français d'Ophtalmologie 2015; 38: 588-594 (IGR: 17-1)


61074 Aflibercept for the treatment of neovascular glaucoma
Seibold LK
Clinical and Experimental Ophthalmology 2015; 43: 803-807 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Pommier S
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61673 Application of anti-VEGF agents in treatment of neovascular glaucoma and anti-scarring in filtering surgery
Duan X
Chinese Journal of Ophthalmology 2015; 51: 314-318 (IGR: 17-1)


61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Sahota DS
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)


61111 Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery
Vandewalle E
Acta Ophthalmologica 2015; 93: 667-678 (IGR: 17-1)


61818 The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome
Turtschi S
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 935-939 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Shobayashi K
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61664 Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
Li QM
Chinese Medical Journal 2015; 128: 2078-2083 (IGR: 17-1)


61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Rostaqui O
Journal Français d'Ophtalmologie 2015; 38: 414-420 (IGR: 17-1)


61500 The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder
Rivero JC
Journal of AAPOS 2015; 19: 322-326 (IGR: 17-1)


61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Sarhan M
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)


61111 Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery
Moons L
Acta Ophthalmologica 2015; 93: 667-678 (IGR: 17-1)


61714 Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis
O'Brien C
Journal of Glaucoma 2016; 25: e99-e105 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Payne R
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61818 The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome
Mozaffarieh M
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 935-939 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Yoganathan P
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Aksoy S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)


61074 Aflibercept for the treatment of neovascular glaucoma
Pantcheva MB
Clinical and Experimental Ophthalmology 2015; 43: 803-807 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Meyer F
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61667 Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
Silva MJ
Arquivos Brasileiros de Oftalmologia 2015; 78: 194-196 (IGR: 17-1)


61060 Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty
Goyette A
Journal Français d'Ophtalmologie 2015; 38: 588-594 (IGR: 17-1)


61111 Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery
Stalmans I
Acta Ophthalmologica 2015; 93: 667-678 (IGR: 17-1)


61714 Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis
Wiggs JL
Journal of Glaucoma 2016; 25: e99-e105 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Chen JC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61074 Aflibercept for the treatment of neovascular glaucoma
Kahook MY
Clinical and Experimental Ophthalmology 2015; 43: 803-807 (IGR: 17-1)


61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Evciman T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)


61664 Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
Wang YY
Chinese Medical Journal 2015; 128: 2078-2083 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Hajjar C
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61060 Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty
Lajoie C
Journal Français d'Ophtalmologie 2015; 38: 588-594 (IGR: 17-1)


61667 Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
Rodrigues Mde L
Arquivos Brasileiros de Oftalmologia 2015; 78: 194-196 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Iwao K
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Souied EH
Journal Français d'Ophtalmologie 2015; 38: 414-420 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Yue BY
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61500 The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder
Boto-de-Los-Bueis A
Journal of AAPOS 2015; 19: 322-326 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Chang JH
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Merite PY
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61667 Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
Cunha Junior Ada S
Arquivos Brasileiros de Oftalmologia 2015; 78: 194-196 (IGR: 17-1)


61060 Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty
Des Marchais B
Journal Français d'Ophtalmologie 2015; 38: 588-594 (IGR: 17-1)


61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Haboğlu M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Fukushima M
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61664 Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
Lyu XB
Chinese Medical Journal 2015; 128: 2078-2083 (IGR: 17-1)


61714 Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis
Pasquale LR
Journal of Glaucoma 2016; 25: e99-e105 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Kherani A; Maberley DA
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Tanihara H
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Parrat E
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61120 Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Ying H
Survey of Ophthalmology 2015; 60: 524-535 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Rouhette H
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Oliver A; Rabinovitch T
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Rebollo O; Matonti F
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)


61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Chen S
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60506 Knowledge and attitudes towards eye diseases in a rural south-eastern Nigerian population
Onwubiko SN
Journal of health care for the poor and underserved 2015; 26: 199-210 (IGR: 16-4)


60554 Clinical Outcomes of Ahmed Glaucoma Valve Implantation With or Without Intravitreal Bevacizumab Pretreatment for Neovascular Glaucoma: A Systematic Review and Meta-Analysis
Zhou M
Journal of Glaucoma 2016; 25: 551-557 (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Kobayashi S
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203 (IGR: 16-4)


60514 Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma
Nagendran ST
Ophthalmic surgery, lasers & imaging retina 2015; 46: 201-207 (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Sahyoun M
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Bressler SB
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60092 The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients
Ozyol P
Journal of Glaucoma 2016; 25: e145-e149 (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Agard E
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Lemos V
Ophthalmologica 2015; 0: (IGR: 16-4)


60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Jiménez-Gómez B
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Freitas-Neto CA
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60731 Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs
Tai TY
Journal of Glaucoma 2015; 24: 311-315 (IGR: 16-4)


60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Caillaux V
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60431 Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Cheng G
Cell biochemistry and biophysics 2015; 0: (IGR: 16-4)


60700 A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
Kitnarong N
Ophthalmology and therapy 2015; 4: 33-41 (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Ho YH
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakata R
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Fakhraie G
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Augustin AJ
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Wang JW
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Ghadimi H
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Elchehab H
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Zhou M
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Zhou MW
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60431 Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Xiang H
Cell biochemistry and biophysics 2015; 0: (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Holz FG
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Maghsoudlou A
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Almukhtar T
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60700 A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
Sriyakul C
Ophthalmology and therapy 2015; 4: 33-41 (IGR: 16-4)


60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Valtot F
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60731 Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs
Moster MR
Journal of Glaucoma 2015; 24: 311-315 (IGR: 16-4)


60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Han JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203 (IGR: 16-4)


60514 Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma
Finger PT
Ophthalmic surgery, lasers & imaging retina 2015; 46: 201-207 (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Inoue M
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60092 The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients
Ozyol E
Journal of Glaucoma 2016; 25: e145-e149 (IGR: 16-4)


60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakisaka T
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Azar G
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60554 Clinical Outcomes of Ahmed Glaucoma Valve Implantation With or Without Intravitreal Bevacizumab Pretreatment for Neovascular Glaucoma: A Systematic Review and Meta-Analysis
Xu X
Journal of Glaucoma 2016; 25: 551-557 (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Chang YC
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
González-Montpetit M
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)


60506 Knowledge and attitudes towards eye diseases in a rural south-eastern Nigerian population
Eze BI
Journal of health care for the poor and underserved 2015; 26: 199-210 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Cabugueira A
Ophthalmologica 2015; 0: (IGR: 16-4)


60092 The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients
Erdoğan BD
Journal of Glaucoma 2016; 25: e145-e149 (IGR: 16-4)


60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Fonollosa Calduch A
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)


60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Souied EH
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Khoueir Z
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Zhang X
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Noronha M
Ophthalmologica 2015; 0: (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Eslami Y
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Yamane S
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Huang WC
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Matsuo H
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)


60431 Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Yang G
Cell biochemistry and biophysics 2015; 0: (IGR: 16-4)


60731 Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs
Pro MJ
Journal of Glaucoma 2015; 24: 311-315 (IGR: 16-4)


60700 A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
Chinwattanakul S
Ophthalmology and therapy 2015; 4: 33-41 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Bhorade A
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Ract-Madoux G
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Wang W
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60506 Knowledge and attitudes towards eye diseases in a rural south-eastern Nigerian population
Udeh NN
Journal of health care for the poor and underserved 2015; 26: 199-210 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Haritoglou C
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Dhanireddy S
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Yim HB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203 (IGR: 16-4)


60554 Clinical Outcomes of Ahmed Glaucoma Valve Implantation With or Without Intravitreal Bevacizumab Pretreatment for Neovascular Glaucoma: A Systematic Review and Meta-Analysis
Zhang X
Journal of Glaucoma 2016; 25: 551-557 (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Chen HY
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Sakamaki K
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Miyata K
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)


60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Orive Bañuelos A
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Mayer WJ
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60431 Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Ma J
Cell biochemistry and biophysics 2015; 0: (IGR: 16-4)


60506 Knowledge and attitudes towards eye diseases in a rural south-eastern Nigerian population
Okoloagu NN
Journal of health care for the poor and underserved 2015; 26: 199-210 (IGR: 16-4)


60554 Clinical Outcomes of Ahmed Glaucoma Valve Implantation With or Without Intravitreal Bevacizumab Pretreatment for Neovascular Glaucoma: A Systematic Review and Meta-Analysis
Sun X
Journal of Glaucoma 2016; 25: 551-557 (IGR: 16-4)


60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Mimoun G
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Bressler NM
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Lee NY
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Huang WB
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Zarei R
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60731 Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs
Myers JS
Journal of Glaucoma 2015; 24: 311-315 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Abegão Pinto L
Ophthalmologica 2015; 0: (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Antoun J
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Russo A
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Wu H
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Payal A
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60431 Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Zhao J
Cell biochemistry and biophysics 2015; 0: (IGR: 16-4)


60731 Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs
Katz LJ
Journal of Glaucoma 2015; 24: 311-315 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Boonsopon S
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Glassman AR
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Lin CC
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Yu X
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Mohammadi M
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Gao XB
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Bopp S
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Reina M
Ophthalmologica 2015; 0: (IGR: 16-4)


60506 Knowledge and attitudes towards eye diseases in a rural south-eastern Nigerian population
Chuka-Okosa CM
Journal of health care for the poor and underserved 2015; 26: 199-210 (IGR: 16-4)


60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Aihara M
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Lagenaite C
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Kourie H
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Arakawa A
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Valsero Franco S
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Scheuerle AF
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60780 Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma
Dot C
Canadian Journal of Ophthalmology 2015; 50: 127-131 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Wang W
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Branco J
Ophthalmologica 2015; 0: (IGR: 16-4)


60255 Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma
Kadonosono K
Journal of Glaucoma 2016; 25: 281-284 (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Nehme J
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60566 Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study
Sung FC
Journal of epidemiology / Japan Epidemiological Association 2015; 25: 15-19 (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Vahedian Z
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Huang W
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Ratwatte MD
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Huang SS
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60547 Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma
Jalkh A
Journal of Glaucoma 2015; 24: 383-388 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Maier M
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Gao X
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Foster CS
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)


60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Gomes T
Ophthalmologica 2015; 0: (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Jampol LM
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Mafi M
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Chen S
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Wang J
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Kim JE
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60093 Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial
Moghimi S
Journal of Glaucoma 2016; 25: e182-e188 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Zhang XY
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Sekundo W; Sandner D
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Li X
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Ding XY
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Melia M
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Du S
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60082 Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma
Jonas JB
Clinical and Experimental Ophthalmology 2015; 43: 415-421 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Shirlaw A
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60563 Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment

JAMA ophthalmology 2015; 0: (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Ding X
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Hattenbach LO
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)


60649 Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes
Zhang X
Acta Ophthalmologica 2015; 93: e556-e560 (IGR: 16-4)


58772 Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma
Semba K; Namekata K; Guo X; Harada C; Harada T; Mitamura Y
Cell Death and Disease 2014; 5: e1333 (IGR: 16-3)


58864 Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients
Murray CD; Wood D; Allgar V; Walters G; Gale RP
Eye 2014; 28: 1218-1222 (IGR: 16-3)


59359 Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide
Morshedi RG; Ricca AM; Wirostko BM
Journal of Glaucoma 2016; 25: 291-300 (IGR: 16-3)


58854 Acute transient myopia with shallowing of the anterior chamber induced by sulfamethoxazole in a patient with pseudoxanthoma elasticum
Araújo JR; Silva SE; Cruz F; Falcão-Reis F
Journal of Glaucoma 2014; 23: 415-417 (IGR: 16-3)


58855 IMPACT ON INTRAOCULAR PRESSURE AFTER 20-MG DECANTED TRIAMCINOLONE ACETONIDE (KENALOG) INJECTION WHEN USING PROPHYLACTIC ANTIGLAUCOMA THERAPY
Barteselli G; Amini P; Ezon IC; Nezgoda JT; Cheng L; Freeman WR
Retina (Philadelphia, Pa.) 2015; 35: 75-81 (IGR: 16-3)


59425 Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma
Zhang HT; Yang YX; Xu YY; Yang RM; Wang BJ; Hu JX
International Journal of Ophthalmology 2014; 7: 837-842 (IGR: 16-3)


58776 Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma
Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
American Journal of Ophthalmology 2014; 158: 693-701.e2 (IGR: 16-3)


58727 Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmologica 2015; 93: e1-e6 (IGR: 16-3)


59517 Surgical Treatment of Neovascular Glaucoma
Fili S; Kohlhaas M; Schilling H; Ligges U; Zelo I
Klinische Monatsblätter für Augenheilkunde 2014; 231: 1230-1238 (IGR: 16-3)


59327 The influence of VEGF inhibitors on corneal endothelium after injection into the anterior chamber in a porcine eye model
Wilhelm A; Sietmann R; Wilhelm U; Hammer T
Ophthalmologe 2015; 112: 346-352 (IGR: 16-3)


59325 Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma
Makri OE; Psachoulia C; Exarchou A; Georgakopoulos CD
Journal of Glaucoma 2016; 25: e53-e55 (IGR: 16-3)


58793 The effect of oral propranolol on intraocular pressure in infants with Sturge-Weber syndrome glaucoma
Wygnanski-Jaffe T; Spierer A; Melamed S; Ben-Zion I
European Journal of Ophthalmology 2014; 0: 0 (IGR: 16-3)


58889 Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
Lemos-Reis R; Moreira-Gonçalves N; Melo AB; Carneiro AM; Falcão-Reis FM
Clinical Ophthalmology 2014; 8: 1383-1388 (IGR: 16-3)


59565 Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management
Kong KL; Khan J
British Journal of Ophthalmology 2015; 99: 1025-1030 (IGR: 16-3)


58893 Safety of topiramate for treating migraines
Marmura MJ
Expert Opinion on Drug Safety 2014; 13: 1241-1247 (IGR: 16-3)


59568 Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population
Mandas A; Mereu RM; Catte O; Saba A; Serchisu L; Costaggiu D; Peiretti E; Caminiti G; Vinci M; Casu M; Piludu S; Fossarello M; Manconi PE; Dessí S
Frontiers in aging neuroscience 2014; 6: 309 (IGR: 16-3)


58737 Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
Boyer DS; Goldbaum M; Leys AM; Starita C;
British Journal of Ophthalmology 2014; 98: 1543-1546 (IGR: 16-3)


58862 Intraocular pressure changes related to intravitreal injections of ranibizumab: analysis of pseudophakia and glaucoma subgroup
Demirel S; Yanik O; Batioglu F; Ozmert E
International Ophthalmology 2015; 35: 541-547 (IGR: 16-3)


58976 Effects of ranibizumab on the extracellular matrix production by human Tenon's fibroblast
Md Noh SM; Sheikh Abdul Kadir SH; Bannur ZM; Froemming GA; Abdul Hamid Hasani N; Mohd Nawawi H; Crowston JG; Vasudevan S
Experimental Eye Research 2014; 127: 236-242 (IGR: 16-3)


59154 Anti-inflammatory Therapy after Selective Laser Trabeculoplasty: A Randomized, Double-Masked, Placebo-Controlled Clinical Trial
Jinapriya D; D'Souza M; Hollands H; El-Defrawy SR; Irrcher I; Smallman D; Farmer JP; Cheung J; Urton T; Day A; Sun X; Campbell RJ
Ophthalmology 2014; 121: 2356-2361 (IGR: 16-3)


59165 Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
Saeed AM; AboulNasr TT
Clinical Ophthalmology 2014; 8: 1745-1755 (IGR: 16-3)


59513 Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
Journal of Glaucoma 2015; 24: 600-606 (IGR: 16-3)


59593 Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy
Martín Giral E; Rivera Zori M; Perucho Martínez S; Toledano Fernández N
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 63-68 (IGR: 16-3)


58758 Ranibizumab Versus Mitomycin C in Primary Trabeculectomy - A Pilot Study
Pro MJ; Freidl KB; Neylan CJ; Sawchyn AK; Wizov SS; Moster MR
Current Eye Research 2014; 0: 1-6 (IGR: 16-3)


56999 Systemic Medication and Intraocular Pressure in a British Population: The EPIC-Norfolk Eye Study
Khawaja AP; Chan MP; Broadway DC; Garway-Heath DF; Luben R; Yip JL; Hayat S; Wareham NJ; Khaw KT; Foster PJ
Ophthalmology 2014; 121: 1501-1507 (IGR: 16-2)


57045 Probable Association of an Attack of Bilateral Acute Angle-Closure Glaucoma With Duloxetine
Shifera AS; Leoncavallo A; Sherwood M
Annals of Pharmacotherapy 2014; 48: 936-939 (IGR: 16-2)


57314 Anterior segment optical coherence tomography documentation of a case of topiramate induced acute angle closure
Mitra A; Ramakrishnan R; Kader MA
Indian Journal of Ophthalmology 2014; 62: 619-622 (IGR: 16-2)


57059 FTY720 protects retinal ganglion cells in experimental glaucoma
You Y; Gupta VK; Li JC; Al-Adawy N; Klistorner A; Graham SL
Investigative Ophthalmology and Visual Science 2014; 55: 3060-3066 (IGR: 16-2)


57039 Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry
Fuest M; Kotliar K; Walter P; Plange N
Ophthalmic and Physiological Optics 2014; 34: 438-444 (IGR: 16-2)


57058 Acute bilateral glaucoma and panuveitis as a side effect of topiramate for weight loss treatment
Pikkel YY
British Medical Journal (Clinical Research Edition) Case Reports 2014; 2014: (IGR: 16-2)


57072 Prolonged mydriasis after inadvertent topical administration of the calcium channel antagonist amlodipine: implications for glaucoma drug development
Roos JC; Haridas AS
Cutaneous and Ocular Toxicology 2015; 34: 84-87 (IGR: 16-2)


56328 Topical bevacizumab for neovascular glaucoma: a pilot study
Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
Pharmacology 2014; 93: 108-112 (IGR: 16-1)


56282 A review of anti-VEGF agents for proliferative diabetic retinopathy
Osaadon P; Fagan XJ; Lifshitz T; Levy J
Eye 2014; 28: 510-520 (IGR: 16-1)


56325 Long-term plasmapheresis in conjunction with thalidomide and dexamethasone for the treatment of cutaneous ulcers and neovascular glaucoma in recalcitrant type I cryoglobulinemia
Yang CH; Qureshi AA; Churchill WH; Saavedra AP
JAMA dermatology 2014; 150: 426-428 (IGR: 16-1)


56342 Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure
Kim YJ; Sung KR; Lee KS; Joe SG; Lee JY; Kim JG; Yoon YH
American Journal of Ophthalmology 2014; 157: 1266-1271 (IGR: 16-1)


56090 Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials
Bakri SJ; Moshfeghi DM; Francom S; Rundle AC; Reshef DS; Lee PP; Schaeffer C; Rubio RG; Lai P
Ophthalmology 2014; 121: 1102-1108 (IGR: 16-1)


56624 The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study
Peng R; Qin G; Li X; Lv H; Qian Z; Yu L
Medical hypothesis, discovery and innovation in ophthalmology 2014; 3: 3-8 (IGR: 16-1)


55159 Anti-vascular endothelial growth factor for neovascular glaucoma
Simha A; Braganza A; Abraham L; Samuel P; Lindsley K
Cochrane Database of Systematic Reviews 2013; 10: CD007920 (IGR: 15-4)


55770 The effect of antivascular endothelial growth factor therapy on the development of neovascular glaucoma after central retinal vein occlusion: a retrospective analysis
Ryu CL; Elfersy A; Desai U; Hessburg T; Edwards P; Gao H
Journal of Ophthalmology 2014; 2014: 317694 (IGR: 15-4)


55297 The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma
Kang JY; Nam KY; Lee SJ; Lee SU
International Ophthalmology 2014; 34: 793-799 (IGR: 15-4)


55733 Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients
Farhood QK; Twfeeq SM
Clinical Ophthalmology 2014; 8: 599-604 (IGR: 15-4)


55678 Combined intracorneal and subconjunctival bevacizumab injections for recurrent visual loss and intraocular hemorrhage from vascularized fibrous downgrowth
Mansour AM
Case Reports in Ophthalmology 2014; 5: 28-33 (IGR: 15-4)


55268 Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study
Vandewalle E; Abegão Pinto L; Van Bergen T; Spielberg L; Fieuws S; Moons L; Spileers W; Zeyen T; Stalmans I
British Journal of Ophthalmology 2014; 98: 73-78 (IGR: 15-4)


55334 The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model
Ozgonul C; Mumcuoglu T; Gunal A
Current Eye Research 2014; 39: 451-459 (IGR: 15-4)


55660 Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: a meta-analysis
Xiong Q; Li Z; Zhu Y; Abdulhalim S; Wang P; Cai X
PLoS ONE 2014; 9: e88403 (IGR: 15-4)


54825 Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgraduate Medicine 2013; 125: 51-58 (IGR: 15-3)


54507 Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series
Lü,ke J; Nassar K; Lü,ke M; Grisanti S
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 2403-2413 (IGR: 15-3)


54525 Regression of iris neovascularization after subconjunctival injection of bevacizumab
Ryoo NK; Lee EJ; Kim TW
Korean Journal of Ophthalmology 2013; 27: 299-303 (IGR: 15-3)


54076 Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study
Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL
Journal of Glaucoma 2013; 22: 526-531 (IGR: 15-3)


54827 Sudden visual loss in the untreated eye of a patient with neovascular glaucoma following an intravitreal bevacizumab injection: A case report
Xu D; Hu L; Wang B; Wang F
Oncology letters 2013; 6: 445-447 (IGR: 15-3)


54418 VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro
Beazley-Long N; Hua J; Jehle T; Hulse RP; Dersch R; Lehrling C; Bevan H; Qiu Y; Lagrè,ze WA; Wynick D; Churchill AJ; Kehoe P; Harper SJ; Bates DO; Donaldson LF
American Journal of Pathology 2013; 183: 918-929 (IGR: 15-3)


54672 Eye on statins: A comprehensive review
Olson EA; Hainsworth DP; Davis G; Hagan JC
Missouri medicine 2013; 110: 344-348 (IGR: 15-3)


54736 Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents
Pershing S; Bakri SJ; Moshfeghi DM
Ophthalmic surgery, lasers & imaging retina 2013; 44: 460-464 (IGR: 15-3)


54817 Effects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case series
Klos-Rola J; Tulidowicz-Bielak M; Zarnowski T
Clinical Ophthalmology 2013; 7: 1929-1935 (IGR: 15-3)


54272 Management of antithrombotic therapies in patients scheduled for eye surgery
Bonhomme F; Hafezi F; Boehlen F; Habre W
European Journal of Anaesthesiology 2013; 30: 449-454 (IGR: 15-3)


53915 Intraocular pressure monitoring post intravitreal steroids: a systematic review
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Survey of Ophthalmology 2013; 58: 291-310 (IGR: 15-2)


53879 Neovascular Glaucoma Treatment With Extraction of Anterior Chamber Fibrovascular Tissue
Nadal J; Carreras E; Kudsieh B; Canut M
JAMA ophthalmology 2013; 0: 1-3 (IGR: 15-2)


53567 Neovascular glaucoma treatment in 2012: role of anti-VEGF agents
Kodjikian L
Journal Français d'Ophtalmologie 2013; 36: 461-465 (IGR: 15-2)


53646 Intracameral Ranibizumab and Subsequent Mitomycin C Augmented Trabeculectomy in Neovascular Glaucoma
Elmekawey H; Khafagy A
Journal of Glaucoma 2014; 23: 437-440 (IGR: 15-2)


54006 Intravitreal Bevacizumab for Ocular Metastasis of Multiple Myeloma
Zhou Q; Liang J; Lu H
Optometry and Vision Science 2013; 90: e236-e240 (IGR: 15-2)


53731 Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab
Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
Investigative Ophthalmology and Visual Science 2013; 54: 3874-3879 (IGR: 15-2)


53652 Comparison of Acetazolamide, Brimonidine, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Initial Intravitreal Bevacizumab Injection: A Randomized Clinical Trial
Katayama BY; Bonini-Filho MA; Messias AM; Paula JS; Martin LF; Costa R; Jorge R
Journal of Glaucoma 2014; 23: 461-463 (IGR: 15-2)


53656 Ocular Decompression With Cotton Swabs Lowers Intraocular Pressure Elevation After Intravitreal Injection
Gregori NZ; Weiss MJ; Goldhardt R; Schiffman JC; Vega E; Mattis CA; Shi W; Kelley L; Hernandez V; Feuer WJ
Journal of Glaucoma 2014; 23: 508-512 (IGR: 15-2)


53640 Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents
Abedi G; Adelman RA; Salim S
Seminars in Ophthalmology 2013; 28: 126-130 (IGR: 15-2)


53649 Does Intravitreal Injections of Bevacizumab for Age-related Macular Degeneration Affect Long-term Intraocular Pressure?
Kim D; Nam WH; Kim HK; Yi K
Journal of Glaucoma 2014; 23: 446-448 (IGR: 15-2)


54024 Identification and determination of major constituents in a traditional Chinese medicine compound recipe Xiongdankaiming tablet using HPLC-PDA/ESI-MS(n) and HPLC-UV/ELSD
Wang SF; Leng J; Xu YM; Feng ML
Journal of Zhejiang University. Science. B 2013; 14: 604-614 (IGR: 15-2)


54049 Botulinum toxin treatment in glaucomatous patients: a pilot study
Librando A; Russo V; Tarallo M; Cruciani F; Carlesimo SC; Nebbioso M
European review for medical and pharmacological sciences 2013; 17: 1835-1838 (IGR: 15-2)


53554 The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
Hazekamp A; Heerdink ER
European Journal of Clinical Pharmacology 2013; 69: 1575-1580 (IGR: 15-2)


54014 Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Freiberg FJ; Matlach J; Grehn F; Karl S; Klink T
Clinical Ophthalmology 2013; 7: 1211-1217 (IGR: 15-2)


53657 A Novel Antiproliferative Drug Coating for Glaucoma Drainage Devices
Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
Journal of Glaucoma 2014; 23: 526-534 (IGR: 15-2)


53617 The Effect of Bevacizumab on the Outcome of Trabeculectomy with 5-Fluorouracil
Suh W; Kee C
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 646-651 (IGR: 15-2)


53742 VEGF induces TGF-β1 expression and myofibroblast transformation after glaucoma surgery
Park HY; Kim JH; Park CK
American Journal of Pathology 2013; 182: 2147-2154 (IGR: 15-2)


53709 Role of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study
Akkan JU; Cilsim S
Journal of Glaucoma 2015; 24: 1-8 (IGR: 15-2)


52684 Long-term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with ranibizumab
Menke MN; Salam A; Framme C; Wolf S
Ophthalmologica 2013; 229: 168-172 (IGR: 15-1)


52414 Secondary Glaucoma After Intravitreal Dexamethasone 0.7 mg Implant in Patients with Retinal Vein Occlusion: A one-Year Follow-Up
Meyer LM; Schönfeld CL
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 560-565 (IGR: 15-1)


52436 High Intraocular Pressure After Carbamazepine and Gabapentin Intake in a Pseudoexfoliative Patient
Atalay E; Tamçelik N; Capar O
Journal of Glaucoma 2014; 23: 574-576 (IGR: 15-1)


52628 Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma
Zhou MW; Wang W; Huang WB; Chen SD; Li XY; Gao XB; Zhang XL
Chinese Medical Journal 2013; 126: 1412-1417 (IGR: 15-1)


52821 Therapy of neovascular glaucoma. The outcome of IOP using concomitant therapy consisting of retinal kryocoagulation, diode laser coagulation, and intravitreal injection of bevacizumab
Seibel I; Breuss H; Kuchenbecker J
Klinische Monatsblätter für Augenheilkunde 2013; 230: 265-269 (IGR: 15-1)


53110 Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma
Chatterjee S; Rao A
Seminars in Ophthalmology 2013; 28: 72-74 (IGR: 15-1)


52614 VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma
Foxton RH; Finkelstein A; Vijay S; Dahlmann-Noor A; Khaw PT; Morgan JE; Shima DT; Ng YS
American Journal of Pathology 2013; 182: 1379-1390 (IGR: 15-1)


52763 Citicoline oral solution in glaucoma: is there a role in slowing disease progression?
Ottobelli L; Manni GL; Centofanti M; Iester M; Allevena F; Rossetti L
Ophthalmologica 2013; 229: 219-226 (IGR: 15-1)


52366 Deep Sclerectomy With Bevacizumab and Mitomycin C: A Comparative Study
Anand N; Bong C
Journal of Glaucoma 2015; 24: 25-31 (IGR: 15-1)


52464 Bevacizumab-Loaded Polyurethane Subconjunctival Implants: Effects on Experimental Glaucoma Filtration Surgery
Paula JS; Ribeiro VR; Chahud F; Cannellini R; Monteiro TC; Gomes EC; Reinach PS; Rodrigues MD; Cunha AS
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 566-573 (IGR: 15-1)


52453 Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas
Biteli LG; Prata TS
International Ophthalmology 2013; 33: 741-746 (IGR: 15-1)


51840 Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection
El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
European Journal of Ophthalmology 2012; 0: 0 (IGR: 14-4)


52061 Effect of Intravitreal Bevacizumab Injection before Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma
Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S
Ophthalmologica 2013; 229: 94-100 (IGR: 14-4)


51976 Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma
Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 1355-1360 (IGR: 14-4)


51860 Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents
Singh RS; Kim JE
Drugs and Aging 2012; 29: 949-956 (IGR: 14-4)


52062 Age-related macular degeneration and glaucoma: intraocular pressure monitoring after intravitreal injections
Avetisov SE; Erichev VP; Budzinskaia MV; Karpilova MA; Gurova IV; Shchegoleva IV; Chikun EA
Vestnik Oftalmologii 2012; 128: 3-5 (IGR: 14-4)


52074 Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties
Mohamed N; Meyer D
Clinical Ophthalmology 2013; 7: 219-227 (IGR: 14-4)


51966 Forskolin and rutin prevent intraocular pressure spikes after Nd:YAG laser iridotomy
Nebbioso M; Belcaro G; Librando A; Rusciano D; Steigerwalt RD; Pescosolido N
Panminerva medica 2012; 54: 77-82 (IGR: 14-4)


51050 ASSOCIATION OF OCT ANGLE RECESS WIDTH WITH IOP RESPONSE AFTER INTRAVITREAL TRIAMCINOLONE INJECTION
Singer MA; Groth SL; Sponsel WE; Herro A; Pollard J; Cohen SR; Cohen JH
Retina (Philadelphia, Pa.) 2013; 33: 282-286 (IGR: 14-3)


51081 Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma
Shim SH; Kim JM; Choi CY; Kim CY; Park KH
Journal of medicinal food 2012; 15: 818-823 (IGR: 14-3)


50965 Efficacy of Intravitreal Bevacizumab With Panretinal Photocoagulation Followed by Ahmed Valve Implantation in Neovascular Glaucoma
Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM
Journal of Glaucoma 2013; 22: 768-772 (IGR: 14-3)


51243 Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab
Park SC; Su D; Tello C
Expert opinion on biological therapy 2012; 12: 1641-1647 (IGR: 14-3)


51377 Intracameral bevacizumab (Avastin(®)) in the management of neovascular glaucoma surgery
Fernández Jiménez-Ortiz H; Perucho Martinez S; Toledano Fernández N; Martin Giral E
Archivos de la Sociedad Española de Oftalmologia 2012; 87: 396-400 (IGR: 14-3)


51390 Anti-VEGF-agents in treatment of neovascular glaucoma

Vestnik Oftalmologii 2012; 128: 50-53 (IGR: 14-3)


51022 Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections
El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
Journal Français d'Ophtalmologie 2012; 35: 614-621 (IGR: 14-3)


50299 Subclinical Increased Anterior Stromal Reflectivity With Topical Taprenepag Isopropyl
Schachar RA; Raber S; Thomas KV; Benetz BA; Szczotka-Flynn LB; Zhang M; Howell SJ; Lass JH
Cornea 2013; 32: 306-312 (IGR: 14-2)


50470 Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model
Husain S; Abdul Y; Crosson CE
Investigative Ophthalmology and Visual Science 2012; 53: 4289-4298 (IGR: 14-2)


49972 Effect on anterior chamber bevacizumab injection combined with seton implantation in treatment of rubeosis iridis in neovascular glaucoma
Altintas AG; Arifoglu HB; Tutar E; Koklu G; Ozcan PY
Cutaneous and Ocular Toxicology 2012; 31: 124-127 (IGR: 14-2)


50000 Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab
Wittströ,m E; Holmberg H; Hvarfner C; André,asson S
European Journal of Ophthalmology 2012; 22: 563-574 (IGR: 14-2)


50543 Trabeculotomy in a Behçet's Disease Patient One Week after Infliximab Administration
Koike A; Handa T; Zako M
Case Reports in Ophthalmology 2012; 3: 151-155 (IGR: 14-2)


50406 Effect of Ginkgo biloba Extract on Visual Field Progression in Normal Tension Glaucoma
Lee J; Sohn SW; Kee C
Journal of Glaucoma 2013; 22: 780-784 (IGR: 14-2)


50634 Glaucoma Filtration Surgery Following Sustained Elevation of Intraocular Pressure Secondary to Intravitreal Anti-VEGF Injections
Skalicky SE; Ho I; Agar A; Bank A
Ophthalmic Surgery Lasers and Imaging 2012; 43: 328-334 (IGR: 14-2)


50585 Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy
Vetrugno M; Uva MG; Russo V; Iester M; Ciancaglini M; Brusini P; Centofanti M; Rossetti LM
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 536-541 (IGR: 14-2)


50608 Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Husain S; Abdul Y; Potter DE
Current Pharmaceutical Design 2012; 18: 6101-6108 (IGR: 14-2)


50575 The Relationship Between Statin Use and Open-Angle Glaucoma
Stein JD; Newman-Casey PA; Talwar N; Nan B; Richards JE; Musch DC
Ophthalmology 2012; 119: 2074-2081 (IGR: 14-2)


50295 Short-term exposure to antidepressant drugs and risk of acute angle-closure glaucoma among older adults
Seitz DP; Campbell RJ; Bell CM; Gill SS; Gruneir A; Herrmann N; Newman AM; Anderson G; Rochon PA
Journal of Clinical Psychopharmacology 2012; 32: 403-407 (IGR: 14-2)


50376 Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
Herná,n Pé,rez de la Ossa D; Ligresti A; Gil-Alegre ME; Aberturas MR; Molpeceres J; Di Marzo V; Torres Suá,rez AI
Journal of Controlled Release 2012; 161: 927-932 (IGR: 14-2)


50564 Intravitreal ranibizumab as an adjunct for ahmed valve surgery in open angle glaucoma: a pilot study1
Desai RU; Singh K; Lin AS
Clinical and Experimental Ophthalmology 2013; 41: 155-158 (IGR: 14-2)


50586 Comparison of Needle Revision with Subconjunctival Bevacizumab and 5-Fluorouracil Injection of Failed Trabeculectomy Blebs
Simsek T; Cankaya AB; Elgin U
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 542-546 (IGR: 14-2)


49949 Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year
Jurkowska-Dudziń,ska J; Kosior-Jarecka E; Zarnowski T
Clinical and Experimental Ophthalmology 2012; 40: e135-e142 (IGR: 14-2)


48727 Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
Kimoto K; Kubota T
Journal of Ophthalmology 2012; 2012: 852183 (IGR: 14-1)


49103 Managing Glaucoma in those with Co-morbidity: Not as Easy as it Seems
Roughead EE; Kalisch LM; Pratt NL; Killer G; Barnard A; Gilbert AL
Ophthalmic Epidemiology 2012; 19: 74-82 (IGR: 14-1)


49169 Urologic medications and ophthalmologic side effects: a review
Gani J; Perlis N; Radomski SB
Canadian Urological Association Journal 2012; 6: 53-58 (IGR: 14-1)


49238 Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study
Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
Clinical and Experimental Ophthalmology 2012; 40: 773-779 (IGR: 14-1)


48962 Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
Sheppard JD; Nguyen QD; Usner DW; Comstock TL
Clinical Ophthalmology 2012; 6: 79-85 (IGR: 14-1)


49283 A LACK OF DELAYED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS TREATED WITH INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
Wehrli SJ; Tawse K; Levin MH; Zaidi A; Pistilli M; Brucker AJ
Retina (Philadelphia, Pa.) 2012; 32: 1295-1301 (IGR: 14-1)


48889 Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study
Marcus MW; Mü,skens RP; Ramdas WD; Wolfs RC; De Jong PT; Vingerling JR; Hofman A; Stricker BH; Jansonius NM
PLoS ONE 2012; 7: e29724 (IGR: 14-1)


48912 Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy
Aref AA
Current Opinions in Ophthalmology 2012; 23: 105-110 (IGR: 14-1)


49244 Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
Graefe's Archive for Clinical and Experimental Ophthalmology 2012; 250: 1435-1440 (IGR: 14-1)


49088 Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma
Cybulska-Heinrich AK; Mozaffarieh M; Flammer J
Molecular Vision 2012; 18: 390-402 (IGR: 14-1)


48267 Management of neovascular glaucoma related to the persistence after retinal detachment surgery of a circumferential peripheral retinal detachment
Delaunay-Suply AC; Cochener B; Gambrelle J
Journal Français d'Ophtalmologie 2011; 34: 711-714 (IGR: 13-4)


47696 Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma
Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; (IGR: 13-4)


47567 Use of sugammadex in a patient with narrow angle glaucoma
Yamamoto M; Murao K; Kimoto M; Inoue S; Kanouda T; Nakamura K; Shingu K
Japanese Journal of Anesthesiology 2011; 60: 1185-1188 (IGR: 13-4)


46934 Glaucoma and ocular surface
Stefan C; Cojocaru I; Pop A
Oftalmologia 2011; 55: 30-33 (IGR: 13-3)


46917 Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
Marey HM; Ellakwa AF
Clinical Ophthalmology 2011; 5: 841-845 (IGR: 13-3)


46562 Treatment of Neovascular Glaucoma after Proton Therapy for Uveal Melanomas with Ranibizumab Injection: Preliminary Results
Caujolle JP; Maschi C; Freton A; Pages G; Gastaud P
Ophthalmic Research 2011; 47: 57-60 (IGR: 13-3)


46740 Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens
Yoshida N; Hisatomi T; Ikeda Y; Kohno R-i; Murakami Y; Imaki H; Ueno A; Fujisawa K; Ishibashi T
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)


47074 Visual recovery in a patient with total hyphema, neovascular glaucoma, long-standing retinal detachment and no light perception vision: A case report
Olawoye O; Teng CC; Shabto U; Liebmann JM; L'Esperance FA; Ritch R
Journal of Medical Case Reports 2011; 5: 221 (IGR: 13-3)


46810 Surgical results of ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
Journal of Glaucoma 2011; (IGR: 13-3)


46903 Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
Canut MI; Alvarez A; Nadal J; Abreu R; Abreu JA; Pulido JS
Clinical Ophthalmology 2011; 5: 715-719 (IGR: 13-3)


46693 Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib
Choi DY; Ortube MC; McCannel CA; Sarraf D; Hubschman J-P; McCannel TA; Gorin MB
Retina (Philadelphia, Pa.) 2011; 31: 1028-1035 (IGR: 13-3)


46380 Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers
Gerometta R; Alvarez LJ; Candia OA
Experimental Eye Research 2011; 93: 103-107 (IGR: 13-3)


46717 Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab
Wu L; Evans T
Archivos de la Sociedad Española de Oftalmologia 2010; 85: 364-369 (IGR: 13-3)


46503 Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
Good TJ; Kimura AE; Mandava N; Kahook MY
British Journal of Ophthalmology 2011; 95: 1111-1114 (IGR: 13-3)


46950 Intraocular pressure changes after different types of intravitreal injections for the treatment of macular edema
Yazici AT; Alagoz C; Alagoz N; Dundar H; Bozkurt E; Cakir M; Yilmaz OF
Retina-Vitreus 2011; 19: 117-121 (IGR: 13-3)


46453 Prophylactic Selective Laser Trabeculoplasty in the Prevention of Intraocular Pressure Elevation after Intravitreal Triamcinolone Acetonide Injection
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
American Journal of Ophthalmology 2011; (IGR: 13-3)


46915 Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
Sedghipour M-R; Mostafaei A; Taghavi Y
Clinical Ophthalmology 2011; 5: 797-800 (IGR: 13-3)


46347 Adjunctive use of bevacizumab versus mitomycin C with ahmed valve implantation in treatment of pediatric glaucoma
Mahdy RA
Journal of Glaucoma 2011; 20: 458-463 (IGR: 13-3)


47014 Adjunctive bevacizumab in patients undergoing Ahmed valve implantation: A pilot study
Rojo-Arnao M; Albis-Donado OD; Lliteras-Cardin M; Kahook MY; Gil-Carrasco F
Ophthalmic Surgery Lasers and Imaging 2011; 42: 132-137 (IGR: 13-3)


45563 Intracellular signaling in human iridial fibroblasts and iridial melanocytes in response to prostaglandins, endothelin, isoproterenol, and other pharmacological agents
Sharif NA; Crider JY
Current Eye Research 2011; 36: 310-320 (IGR: 13-2)


46045 Antidepressants and risk of acute angle closure glaucoma in older adults
Seitz D; Campbell R; Bell C; Gill S; Gruneir A; Herrmann N; Anderson G; Rochon P
American Journal of Geriatric Psychiatry 2011; 19: 95-96 (IGR: 13-2)


46307 Temporary intraocular pressure lowering by photodynamic therapy in pseudoexfoliation glaucoma
Parodi MB; Iacono P; Bandello F
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2011; 42: 53-58 (IGR: 13-2)


45471 Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab
Fong AW; Lee GA; O'Rourke P; Thomas R
Clinical and Experimental Ophthalmology 2011; 39: 318-323 (IGR: 13-2)


46011 Silicone Ahmed glaucoma valve with and without intravitreal triamcinolone acetonide for neovascular glaucoma: Randomized clinical trial
Teixeira SH; Doi LM; de Freitas Silva AL; Silva KD; Paes AT; Higa FS; Mendonca M; Prata JA; Paranhos A
Journal of Glaucoma 2011; (IGR: 13-2)


45680 Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma
Wolf A; von Jagow B; Ulbig M; Haritoglou C
Ophthalmologica 2011; 226: 51-56 (IGR: 13-2)


45755 Intraocular Pressure Outcome of Patients with Fluocinolone Acetonide Intravitreal Implant for Noninfectious Uveitis
Bollinger K; Kim J; Lowder CY; Kaiser PK; Smith SD
Ophthalmology 2011; (IGR: 13-2)


45990 The influence of topical diclofenac sodium on the ocular hypotensive effect of latanoprost in glaucoma patients
Sorkhabi R; Alipanahi R; Eftakhari-Milani A; Ghojazadeh L
Journal of Glaucoma 2011; 20: 240-243 (IGR: 13-2)


46165 ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol
Bochmann F; Kaufmann C; Becht CN; Guber I; Kaiser M; Bachmann LM; Thiel MA
BMC Ophthalmology 2011; 11: 1 (IGR: 13-2)


45529 Sustained ocular hypertension following intravitreal injections of 0.5 mg/0.05 ml ranibizumab
Loukianou E; Brouzas D; Apostolopoulos M
International Ophthalmology 2011; 31: 211-213 (IGR: 13-2)


45569 Anti-Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration Surgery
Mathew R; Barton K
American Journal of Ophthalmology 2011; 152: 10-15 (IGR: 13-2)


46029 Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration
Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
Journal of Glaucoma 2011; (IGR: 13-2)


45982 Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial
Sengupta S; Venkatesh R; Ravindran RD
Journal of Glaucoma 2011; (IGR: 13-2)


27816 Intravitreal bevacizumab in refractory neovascular glaucoma: A prospective, observational case series
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Archives of Ophthalmology 2011; 129: 145-150 (IGR: 13-1)


28154 Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion
Kodama A; Sugioka K; Kuniyoshi K; Okuyama S; Matsumoto C; Shimomura Y
Clinical Ophthalmology 2010; 4: 1177-1180 (IGR: 13-1)


27927 Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: A phase i clinical trial
Heier JS; Brown D; Ciulla T; Abraham P; Bankert JM; Chong S; Daniel Jr PE; Kim IK
Ophthalmology 2011; 118: 111-118 (IGR: 13-1)


28128 Langerhans cell histiocytosis of the uvea with neovascular glaucoma: Diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy
Shields CL; Hogarty MD; Kligman BE; Christian C; Ehya H; Shields JA
Journal of AAPOS 2010; 14: 534-537 (IGR: 13-1)


27686 Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma
Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
Journal of Glaucoma 2011; 20: 196-201 (IGR: 13-1)


27953 Antivascular endothelial growth factors in anterior segment diseases
Scholl S; Kirchhof J; Augustin AJ
Developments in Ophthalmology 2010; 46: 133-139 (IGR: 13-1)


27897 Intravitreal triamcinolone
Tao Y; Jonas JB
Ophthalmologica 2011; 225: 1-20 (IGR: 13-1)


27377 Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A
Chien K-H; Lu D-W; Chen Y-H; Cheng J-H; Chen J-T
Journal of Glaucoma 2010; 19: 546-550 (IGR: 12-4)


27125 A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes
Hollands H; Seif G; Hollands S; Gale J
Canadian Journal of Ophthalmology 2010; 45: 484-488 (IGR: 12-4)


27599 Intravitreal becacizumab treatment the neovascular glaucoma as an adjunct method
Wang L-L; Jin L-Y; Li L-J; Zhang W; Huo M
International Journal of Ophthalmology 2010; 10: 1903-1905 (IGR: 12-4)


27303 Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients
Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1601-1609 (IGR: 12-4)


27013 Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
Journal of Glaucoma 2010; 19: 622-626 (IGR: 12-4)


27421 Resolution of lymphoma-associated open-angle glaucoma by rituximab
Kim WI; Larar JG; Cheson BD; Lee RK; Palmberg PF
Journal of Glaucoma 2010; (IGR: 12-4)


27212 Acute bilateral angle-closure glaucoma induced by topiramate: Contribution of Visante((registered trademark)) OCT
Tahiri Joutei Hassani R; Dupont Monod S; Oukacha G; Mantout F; Benrabah R; Heron E; Baudouin C
Journal Français d'Ophtalmologie 2010; 33: 307-311 (IGR: 12-4)


27297 Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application
Hohn F; Mirshahi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1371-1375 (IGR: 12-4)


27213 Glaucoma management during pregnancy
Denis D; Touvron G
Journal Français d'Ophtalmologie 2010; 33: 346-349 (IGR: 12-4)


27255 Vascular endothelial growth factor (VEGF) and modulation of wound healing after glaucoma surgery
Stalmans I; Vandewalle E; Van Bergen T
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 2010; 72: 41-53 (IGR: 12-4)


26939 Effect of Prophylactic Intraocular Pressure–Lowering Medication on Intraocular Pressure Spikes After Intravitreal Injections
MPC Frenkel; SA Haji; REP Frenkel
Archives of Ophthalmology 2010; 128: 1523-1527 (IGR: 12-4)


27249 Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas
Dada T; Bhartiya S; Vanathi M; Panda A
Indian Journal of Ophthalmology 2010; 58: 440-442 (IGR: 12-4)


27053 Antifibrotic Activity of Bevacizumab on Human Tenon's Fibroblasts In Vitro.
O'Neill EC; Qin Q; Van Bergen NJ; Connell PP; Vasudevan S; Coote MA; Trounce IA; Wong TT; Crowston JG
Investigative Ophthalmology and Visual Science 2010; 51: 6524-6532 (IGR: 12-4)


26466 Use of bevacizumab as an additional strategy in angle closure glaucoma--case report
Helemejko I; Jurowska-Liput J
Klinika Oczna 2010; 112: 61-62 (IGR: 12-3)


26834 Clinical effect and nursing of neovascular glaucoma patients treated by intravitreous injection of Avastin combined with trabeculectomy
Zhu X-L; Xiao S-Y; Li Q; Wu X-F; Liao Y
International Journal of Ophthalmology 2010; 10: 1211-1213 (IGR: 12-3)


26846 Four joint surgery in the treatment of neovascular glaucoma
Cao J-G; Yan Q-H; Bao Y-L; Li Y
International Journal of Ophthalmology 2010; 10: 1152-1153 (IGR: 12-3)


26673 Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion
Chuang L-H; Yeung L; Wang N-K; Chen HS-L; Ku W-C; Lai C-C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 325-328 (IGR: 12-3)


26592 Depression and sleep disorders in progressed glaucoma: An indication for melatonergic antidepressants?
Agorastos A; Skevas C; Matthaei M; Huber CG
European Psychiatry 2010; 25 (IGR: 12-3)


26802 Hypotensive medication, statins, and the risk of glaucoma
Owen CG; Carey IM; Shah S; De Wilde S; Wormald R; Whincup PH; Cook DG
Investigative Ophthalmology and Visual Science 2010; 51: 3524-3530 (IGR: 12-3)


26737 The influence of carteolol and pentoxyphylin on the visual field in glaucoma patients - Case reports of selected patients
Machu V
?eska a Slovenska Oftalmologie 2010; 66: 39-42 (IGR: 12-3)


26597 Clinical uses of melatonin: Evaluation of human trials
Sanchez-Barcelo EJ; Mediavilla MD; Tan DX; Reiter RJ
Current Medicinal Chemistry 2010; 17: 2070-2095 (IGR: 12-3)


26377 Hypotensive effect of juxtascleral administration of anecortave acetate in different types of glaucoma
Prata TS; Tavares IM; Mello PA; Tamura C; Lima VC; Belfort R
Journal of Glaucoma 2010; 19: 488-492 (IGR: 12-3)


26828 Clinical observation of carbamycholine in glaucoma and cataract surgery
Xu C-L; Li L; Gao X-W; Li X; Yang Y-L; Dong X-Y
International Journal of Ophthalmology 2010; 10: 1543-1544 (IGR: 12-3)


26412 Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: A pilot study
Kahook MY
American Journal of Ophthalmology 2010; 150: 399-403 (IGR: 12-3)


26583 Melatonin as a therapeutic tool in ophthalmology: Implications for glaucoma and uveitis
Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
Journal of Pineal Research 2010; 49: 1-13 (IGR: 12-3)


26675 Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma
Gupta S; Samanta MK
Pharmaceutical Development and Technology 2010; 15: 386-393 (IGR: 12-3)


26509 Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: A randomized controlled trial
Breusegem C; Spielberg L; Van Ginderdeuren R; Vandewalle E; Renier C; Van de Veire S; Fieuws S; Zeyen T; Stalmans I
Ophthalmology 2010; 117: 1324-1330 (IGR: 12-3)


26103 Effects of sildenafil and tadalafil on intraocular pressure in sheep: implications for aqueous humor dynamics
Gerometta R; Alvarez LJ; Candia OA
Investigative Ophthalmology and Visual Science 2010; 51: 3139-3144 (IGR: 12-2)


26160 Acute bilateral angle-closure glaucoma induced by topiramate: contribution of Visante OCT
Tahiri Joutei Hassani R; Dupont Monod S; Oukacha G; Mantout F; Benrabah R; Heron E; Baudouin C
Journal Français d'Ophtalmologie 2010; 33: 307-311 (IGR: 12-2)


26097 Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer
Deschênes MC; Descovich D; Moreau M; Granger L; Kuchel GA; Mikkola TS; Fick GH; Chemtob S; Vaucher E; Lesk MR
Investigative Ophthalmology and Visual Science 2010; 51: 2587-2600 (IGR: 12-2)


25831 Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma
Chen C-H; Lai I-C; Wu P-C; Chen Y-J; Chen Y-H; Lee J-J; Liu Y-C; Kuo H-K
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 111-118 (IGR: 12-2)


26145 Surgical Outcomes of Intravitreal Bevacizumab and Guarded Filtration Surgery in Neovascular Glaucoma
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
Journal of Glaucoma 2010; 19: 212-218 (IGR: 12-2)


26250 Therapeutic effect of bevacizumab injected into the silicone oil in eyes withneovascular glaucoma after vitrectomy for advanced diabetic retinopathy
Falavarjani KG; Modarres M; Nazari H
Eye 2010; 24: 717-719 (IGR: 12-2)


26203 Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma
Malone PE; Herndon LW; Muir KW; Jaffe GJ
American Journal of Ophthalmology 2010; 149: 800-806 (IGR: 12-2)


25732 Afect of botulinum toxin-A injection on intraocular pressure and proptosis in thyroid associated orbitopathy
Lesin M; Bojic L; Romac R; Lesin J; Ivanisevic M; Galetovic D; Rogosic V
Collegium Antropologicum 2009; 33: 1155-1157 (IGR: 12-2)


25833 Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections
Adelman RA; Zheng Q; Mayer HR
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 105-110 (IGR: 12-2)


25811 Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series
Choi JY; Choi J; Kim YD
Korean Journal of Ophthalmology 2010; 24: 47-52 (IGR: 12-2)


26025 Study of treating the bleb fibrosis after trabeculectomy with Avastin
Lu J; Lai M-Y; Ying F-W; Huang L-N; Cheng H-B
International Journal of Ophthalmology 2010; 10: 446-448 (IGR: 12-2)


25870 Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
Georgalas I; Papaconstantinou D; Tservakis I; Koutsandrea C; Ladas I
Therapeutics and Clinical Risk Management 2009; 5: 17-19 (IGR: 12-2)


26283 Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma
Ghosh S; Singh D; Ruddle JB; Shiu M; Coote MA; Crowston JG
Clinical and Experimental Ophthalmology 2010; 38: 353-357 (IGR: 12-2)


26269 Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery
Karalezli A; Borazan M; Kucukerdonmez C; Akman A; Akova YA
Eye 2010; 24: 619-623 (IGR: 12-2)


25245 Simvastatin and Disease Stabilization in Normal Tension Glaucoma: A Cohort Study
Leung DY; Li FC; Kwong YY; Tham CC; Chi SC; Lam DS
Ophthalmology 2010; 117: 471-476 (IGR: 12-1)


25552 Clinical observation of panretinal photocoagulation, vitrectomy combined with pars plana Ahmed glaucoma valve implantation for neovascular glaucoma
Li S -H; Ye J; He X -G
International Journal of Ophthalmology 2009; 9: 1890-1891 (IGR: 12-1)


25623 Anterior chamber bevacizumab for rubeotic glaucoma secondary to retinal artery occlusion
Bhojwani R; Kelly S P
Artery Research 2009; 3: 122-123 (IGR: 12-1)


25470 Bevacizumab (Avastin(registered trademark)) for the management of anterior chamber neovascularization and neovascular glaucoma
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clinical Ophthalmology 2009; 3: 685-688 (IGR: 12-1)


25357 Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab
Lupinacci A P C; Calzada J I; Rafieetery M; Charles S; Netland P A
Advances in Therapy 2009; 26: 208-216 (IGR: 12-1)


25592 Bevacizumab as adjuvant for neovascular glaucoma
Beutel J; Peters S; Luke M; Aisenbrey S; Szurman P; Spitzer M S; Yoeruek E; Grisanti S
Acta Ophthalmologica 2010; 88: 103-109 (IGR: 12-1)


25422 Intravitreal bevacizumab for neovascular glaucoma
Vasudev D; Blair M P; Galasso J; Kapur R; Vajaranant T
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 453-458 (IGR: 12-1)


25600 Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma
Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
Acta Ophthalmologica 2010; 88: 96-102 (IGR: 12-1)


25407 Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim T H; Bae S H; Cho Y J; Lee J H; Kim H K; Sohn Y H
Korean Journal of Ophthalmology 2009; 23: 188-192 (IGR: 12-1)


25404 Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
Sagong M; Kim J; Chang W
Korean Journal of Ophthalmology 2009; 23: 215-218 (IGR: 12-1)


25618 Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: A case report
Alasil T; Rauser M E
Cases Journal 2009; 2: 10: 176 (IGR: 12-1)


25517 Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy
Liu L; Wu W -C; Yeung L; Wang N -K; Kuo Y -H; Chao A -N; Chen K -J; Chen T -L; Lai C -C; Hwang Y -S
Ophthalmic Surgery Lasers and Imaging 2010; 41: 72-77 (IGR: 12-1)


25201 Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis)
Sharei V; Höhn F; Köhler T; Hattenbach LO; Mirshahi A
European Journal of Ophthalmology 2010; 20: 174-179 (IGR: 12-1)


25087 Anti-VEGF therapy for glaucoma
Horsley MB; Kahook MY
Current Opinions in Ophthalmology 2010; 21: 112-117 (IGR: 12-1)


25397 Advance in the study of complication of anti-vascular endothelial growth factor following intravitreal injection
Meng L; Chen S
Chinese Ophthalmic Research 2009; 27: 1039-1043 (IGR: 12-1)


25553 Analysis of incidence rate and risk factors of secondary glaucoma after intravitreal injection of triamcinolone acetonide
Liu C -N; Li Y -T
International Journal of Ophthalmology 2009; 9: 1972-1973 (IGR: 12-1)


25292 Selective trabeculoplasty in combination with vasoactive agents in the complex treatment of primary open-angle glaucoma
Shaimova V A; Shaimov R B; Goloshchapov K P
Vestnik Oftalmologii 2009; 125: 28-31 (IGR: 12-1)


25459 Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
Kahook M Y; Camejo L; Noecker R J
Clinical Ophthalmology 2009; 3: 29-31 (IGR: 12-1)


25454 Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma
Chang D T W; Herceg M C; Bilonick R A; Camejo L; Schuman J S; Noecker R J
Clinical Ophthalmology 2009; 3: 345-355 (IGR: 12-1)


24616 The neuroprotective effect of extact of ginko biloba on retinal ganglion cells after retinal ischemia-reperfusion
Li Y; Ma K; Xu L
Chinese Ophthalmic Research 2009; 27: 660-663 (IGR: 11-4)


24665 The effect of trans-tenon triamcinolone acetonide injection on intraocular pressure in diffuse diabetic macular edema
Cumurcu T; Kilic R; Erkorkmaz U
Trakya Universitesi Tip Fakultesi Dergisi 2008; 25: 15-19 (IGR: 11-4)


24574 Assessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agents
Seth RK; Salim S; Shields MB; Adelman RA
Retina (Philadelphia, Pa.) 2009; 29: 956-959 (IGR: 11-4)


24972 Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Japanese Journal of Ophthalmology 2009; 53: 519-522 (IGR: 11-4)


24856 Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma
Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
European Journal of Ophthalmology 2009; 19: 1029-1034 (IGR: 11-4)


24809 Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
Journal of Glaucoma 2009; 18: 632-637 (IGR: 11-4)


24673 Antiangiogenic treatment for neovascular glaucoma and after filtering surgery
Luke J; Luke M; Grisanti S
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2009; 106: 407-412 (IGR: 11-4)


24815 In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
Journal of Glaucoma 2009; 18: 589-594 (IGR: 11-4)


24621 Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome
Lee SJ; Lee JJ; Kim SY; Kim SD
Korean Journal of Ophthalmology 2009; 23: 132-134 (IGR: 11-4)


24991 Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
Journal Français d'Ophtalmologie 2009; 32: 652-663 (IGR: 11-4)


24771 Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: A case-report
Spaccapelo L; Leschiutta S; Aurea C; Ferrari A
Cases Journal 2009; 2: 87 (IGR: 11-4)


24986 Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion
Qureshi K; Kashani S; Kelly SP
International Ophthalmology 2009; 29: 537-539 (IGR: 11-4)


24525 Bilateral acute angle closure glaucoma and myopia induced by topiramate
Cruciani F; Lorenzatti M; Nazzarro V; Abdolrahimzadeh S
Clinica Terapeutica 2009; 160: 215-216 (IGR: 11-4)


24954 Topiramate and asymptomatic ocular angle narrowing: a prospective pilot study
Leung DYL; Leung H; Baig N; Kwan P; Kwong YYK; Wong KS; Lam DSC
Eye 2009; 23: 2079-2081 (IGR: 11-4)


24768 Iatrogenic glaucoma therapy failure: The adverse effects of topical antiglaucoma medication treatment outcome
Mirza SK; Higginbotham EJ
Expert Review of Clinical Pharmacology 2009; 2: 87-99 (IGR: 11-4)


24882 Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery
Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L
Investigative Ophthalmology and Visual Science 2009; 50: 5217-5225 (IGR: 11-4)


24409 Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections
Kahook MY; Kimura AE; Wong LJ; Ammar DA; Maycotte MA; Mandava N
Ophthalmic Surgery Lasers and Imaging 2009; 40: 293-295 (IGR: 11-3)


24221 Unilatelaral iris plateau syndrome after the use of ecstasy
Jovanovic P; Hentova-Sencanic P; Zoric L; Petrovic M; Bozinovic MT
Vojnosanitetski pregled. Military-medical and pharmaceutical review 2009; 66: 487-489 (IGR: 11-3)


24482 Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: A case series
De Moraes CGV; Facio Jr AC; Costa JH; Malta RFS
Journal of Ocular Biology, Diseases, and Informatics 2009; 2: 40-46 (IGR: 11-3)


24102 Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Canadian Journal of Ophthalmology 2009; 44: 451-456 (IGR: 11-3)


24392 Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma
Wasik A; Song H-F; Grimes A; Engelke C; Thomas A
Optometry 2009; 80: 243-248 (IGR: 11-3)


24341 Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma
Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 259-263 (IGR: 11-3)


24388 Memantine: A comprehensive review of safety and efficacy
Kavirajan H
Expert Opinion on Drug Safety 2009; 8: 89-109 (IGR: 11-3)


24413 Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions
Aggarwal SK; Carter GT; Sullivan MD; ZumBrunnen C; Morrill R; Mayer JD
Journal of Opioid Management 2009; 5: 153-168 (IGR: 11-3)


24423 Selective serotonin reuptake inhibitors: A review of its effects on intraocular pressure
Costagliola C; Parmeggiani F; Semeraro F; Sebastiani A
Current Neuropharmacology 2008; 6: 293-310 (IGR: 11-3)


24237 Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
Hanus LO
Medicinal Research Reviews 2009; 29: 213-271 (IGR: 11-3)


24063 Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma
Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
European Journal of Ophthalmology 2009; 19: 607-612 (IGR: 11-3)


24260 Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MVW; Einarson TR
Current Medical Research and Opinion 2009; 25: 1879-1888 (IGR: 11-3)


24402 Needle bleb revision with bevacizumab
Kahook MY
Techniques in Ophthalmology 2008; 6: 111-113 (IGR: 11-3)


24039 Phosphodiesterase inhibitors and the eye
Kerr NM; Danesh-Meyer HV
Clinical and Experimental Ophthalmology 2009; 37: 514-523 (IGR: 11-3)


24506 The association between self-reported glaucoma and ginkgo biloba use
Khoury R; Cross JM; Girkin CA; Owsley C; McGwin G Jr
Journal of Glaucoma 2009; 18: 543-545 (IGR: 11-3)


24065 Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure
Shimura M; Yasuda K; Nakazawa T; Shiono T; Sakamoto T; Nishida K
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 907-912 (IGR: 11-3)


24064 The effects of raloxifene hydrochloride on ocular hemodynamics and visual function
Siesky B; Harris A; Kheradiya N; Ehrlich R; Klaas C; Kaplan B; Catoira Y; McCranor L; Rospigliosi C; Harris M
International Ophthalmology 2009; 29: 225-230 (IGR: 11-3)


24361 Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Tsiropoulos I; Andersen M; Hallas J
Pharmacoepidemiology and Drug Safety 2009; 18: 483-491 (IGR: 11-3)


24095 Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit
Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
Investigative Ophthalmology and Visual Science 2009; 50: 3233-3237 (IGR: 11-3)


24338 Ocular complications of cancer therapy: A primer for the ophthalmologist treating cancer patients
Hazin R; Abuzetun JY; Daoud YJ; Abu-Khalaf MM
Current Opinions in Ophthalmology 2009; 20: 308-317 (IGR: 11-3)


23922 The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma
Gupta V; Jha R; Rao A; Kong G; Sihota R
European Journal of Ophthalmology 2009; 19: 435-441 (IGR: 11-2)


23480 Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: Systematic review
Martinez-Carpio PA; Bonafonte-Marquez E; Heredia-Garcia CD; Bonafonte-Royo S
Archivos de la Sociedad Española de Oftalmologia 2008; 83: 579-587 (IGR: 11-2)


23808 Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
British Journal of Ophthalmology 2009; 93: 589-593 (IGR: 11-2)


23897 Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients
Cornish KS; Ramamurthi S; Saidkasimova S; Ramaesh K
Eye 2009; 23: 979-981 (IGR: 11-2)


23651 Angiogenesis: trabeculectomy and bevacizumab
Jue A
Seminars in Ophthalmology 2009; 24: 122-125 (IGR: 11-2)


22505 Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab
Bakri SJ; Pulido JS; McCannel CA; Hodge DO; Diehl N; Hillemeier J
Eye 2009; 23: 181-185 (IGR: 11-1)


22525 Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection
Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
Investigative Ophthalmology and Visual Science 2009; 50: 573-576 (IGR: 11-1)


22865 Intravitreal bevacizumab for neovascular glaucoma
Andrijevic-Derk B; Vatavuk Z; Bencic G; Novak-Laus K; Mandic Z
Acta Clinica Croatica 2008; 47: 175-179 (IGR: 11-1)


22945 The treatment of the rubeosis of the iris and the neovascular glaucoma in proliferative diabetic retinopathy by means of anti-VEGF
Cernak M; Markovic O; Cernak A
?eska a Slovenska Oftalmologie 2008; 64: 234-236 (IGR: 11-1)


22860 Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: A survey on 23 cases throughout 12-month follow-up
Costagliola C; Cipollone U; Rinaldi M; Della Corte M; Semeraro F; Romano MR
British Journal of Clinical Pharmacology 2008; 66: 667-673+750 (IGR: 11-1)


22877 Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma
Kitnarong N; Chindasub P; Metheetrairut A
Advances in Therapy 2008; 25: 438-443 (IGR: 11-1)


22840 Ocular adverse effects of Topiramate: Two case reports
Mandal A; Chatterjee S; Bose S; Ganguly G
Indian Journal of Pharmacology 2008; 40: 278-280 (IGR: 11-1)


22552 Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide)
Byeon SH; Kwon OW; Song JH; Kim SE; Park YS
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 35-42 (IGR: 11-1)


22558 Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J; Alcon Anecortave Acetate for IOP Research Team
Archives of Ophthalmology 2009; 127: 173-178 (IGR: 11-1)


22574 Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation
Robin AL; Clark AF; Covert DW; Krueger S; Bergamini MV; Landry TA; Dickerson JE Jr; Scheib SA; Realini T; Defaller JM
American Journal of Ophthalmology 2009; 147: 45-50 (IGR: 11-1)


21123 Intravitreal micronized triamcinolone versus triamcinolone acetonide: A clinical and morphological comparative study
Salvolini E; Neri P; Orciani M; Di Primio R; Giovannini A
International Journal of Immunopathology and Pharmacology 2008; 21: 181-188 (IGR: 10-2)


21101 Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina (Philadelphia, Pa.) 2008; 28: 696-702 (IGR: 10-2)


21117 Intraocular avastin (bevacizumab) for neovascularisation of the iris and neovascular glaucoma
Cheng JYC; Wong DWK; Chong LA
Annals of the Academy of Medicine, Singapore 2008; 37: 72-74 (IGR: 10-2)


21152 Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Andreoli CM; Miller JW
Current Opinions in Ophthalmology 2007; 18: 502-508 (IGR: 10-2)


21037 Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost
Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
Current Eye Research 2008; 33: 477-482 (IGR: 10-2)


21210 Gabapentin therapy for painful, blind glaucomatous eye: Case report
Kavalieratos C-S; Dimou T
Pain Medicine 2008; 9: 377-378 (IGR: 10-2)


21059 Pharmacology and clinical relevance of vasopressin antagonists
Lemmens-Gruber R; Kamyar M
Internist 2008; 49: 628-634 (IGR: 10-2)


21086 Ocular side effects in chronic myeloid leukemia patients treated with imatinib
Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
Leukemia Research 2008; 32: 1022-1025 (IGR: 10-2)


21007 Anticoagulation therapy in glaucoma surgery
Alwitry A; King AJ; Vernon SA
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 891-896 (IGR: 10-2)


21361 Penetration of topically applied levofloxacin into eyes with thin-wall filtering bleb after trabeculectomy
Qiao LY; Wang NL; Liang YB; Zhu SQ; Wan XH; Lee PY
Eye 2008; 22: 666-670 (IGR: 10-2)


20893 Sodium hyaluronate eye drops prevent late-onset bleb leakage after trabeculectomy with mitomycin C
Sagara H; Iida T; Suzuki K; Fujiwara T; Koizumi H; Yago K
Eye 2008; 22: 507-514 (IGR: 10-2)


20621 Role of intravitreal bevacizumab in neovascular glaucoma
Gheith ME; Siam GA; Monteiro de Barros DS; Garg SJ; Moster MR
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 487-491 (IGR: 10-1)


20620 Bilateral severe fibrinous anterior uveitis - An unusual complication of pamidronate therapy exacerbated by topical latanoprost
Ramasamy B; Quah S; Sahni JN; Palimar P
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 513-515 (IGR: 10-1)


20052 Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study
Jin X; Xue A; Zhao Y; Qin Q; Dong XD; Qu J
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 1611-1616 (IGR: 9-4)


19729 Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma
Trichopoulos N; Damato B
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 1573-1575 (IGR: 9-4)


19830 History of cannabis and its preparations in saga, science, and sobriquet
Russo EB
Chemistry and Biodiversity 2007; 4: 1614-1648 (IGR: 9-4)


19939 Peribulbar tramadol, clonidine, and ropivacaine in blind and seeing painful eyes
Tarantini A; Lanzetta P; Cugini U
European Journal of Ophthalmology 2007; 17: 976-978 (IGR: 9-4)


19328 Inhibition of angiogenesis in the anterior chamber of the eye
Bock F; Konig Y; Dietrich T; Zimmermann P; Baier M; Cursiefen C
Ophthalmologe 2007; 104: 336-344 (IGR: 9-3)


19452 Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy
De Castro DK; Punjabi OS; Bostrom AG; Stamper RL; Lietman TM; Ray K; Lin SC
Clinical and Experimental Ophthalmology 2007; 35: 506-513 (IGR: 9-3)


17439 Medical marijuana and the developing role of the pharmacist
Seamon MJ; Fass JA; Maniscalco-Feichtl M; Abu-Shraie NA
American Journal of Health-System Pharmacy 2007; 64: 1037-1044 (IGR: 9-2)


14619 Protective effect of Erigeron Breviscapus (Vant.) Hangd-Mazz on the visual field of glaucoma with controlled intraocular pressure
Xiang M-H; Zhong Y-S; Zhang X-R
International Journal of Ophthalmology 2006; 6: 806-809 (IGR: 8-4)


14017 Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use
Dundar SO; Topalo Gcaron Lu A; Dundar M; Kocak I
Eye 2006; 20: 810-813 (IGR: 8-3)


13957 Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women
Khurana RN; Labree LD; Scott G; Smith RE; Yiu SC
American Journal of Ophthalmology 2006; 142: 494-495 (IGR: 8-3)


14279 Therapeutic potentials of aspirin in glaucomatous optic neuropathy
Attarzadeh A; Hosseini H; Nowroozizadeh S
Medical Hypotheses 2006; 67: 375-377 (IGR: 8-3)


14233 Effect of sildenafil on ocular hemodynamics in 3 months regular use
Dundar SO; Dayanir Y; Topaloglu A; Dundar M; Kocak I
International Journal of Impotence Research 2006; 18: 282-286 (IGR: 8-3)


13901 Alterations in human trabecular meshwork cell homeostasis by selenium
Conley SM; McKay BS; Gandolfi AJ; Stamer WD
Experimental Eye Research 2006; 82: 637-647 (IGR: 8-2)


13625 Effect of oxymetazoline nasal spray on intraocular pressure and retrobulbar hemodynamics
Arikan OK; Akarsu C; Unal B; Ergin A; Koc C
Journal of Otolaryngology 2006; 35: 30-35 (IGR: 8-2)


13415 Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma
Costagliola C; Parmeggiani F; Caccavale A; Sebastiani A
American Journal of Ophthalmology 2006; 141: 379-381 (IGR: 8-1)


13295 New pharmacological perspectives of melatonin in the treatment of ocular pathologies
Pintor J
Anales de la Real Academia Nacional de Farmacia 2005; 71: 429-438 (IGR: 8-1)


12989 The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Experimental Eye Research 2005; 81: 610-615 (IGR: 7-3)


12212 Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis
Kuo H-K; Lai I-C; Fang P-C; Teng M-C
Chang Gung medical journal 2005; 28: 85-89 (IGR: 7-2)


12355 Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial
Lam DS; Fan DS; Ng JS; Yu CB; Wong CY; Cheung AY
Clinical and Experimental Ophthalmology 2005; 33: 252-258 (IGR: 7-2)


12273 Dramatic decrease in intraocular pressure following topical administration of cycloplegics in an aphakic child
Salam GA; Rothman R; Granet DB; Kodsi S
Journal of AAPOS 2005; 9: 198-199 (IGR: 7-2)


12532 Effects of cholesterol-lowering statins on the aqueous humor outflow pathway
Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
Investigative Ophthalmology and Visual Science 2005; 46: 2424-2432 (IGR: 7-2)


11851 Can selective serotonin reuptake inhibitor antidepressants cause glaucomas?
Kuzmanovic I; Vogt-Ferrier N
Medecine et Hygiene 2004; 62: 2289-2294 (IGR: 7-1)


12024 Herb and vitamin supplementation use among a general ophthalmology practice population
West AL; Fetters MD; Hemmila MR; Gorenflo DW; Kiyota A; Moroi-Fetters S
American Journal of Ophthalmology 2005; 139: 522-529 (IGR: 7-1)


11315 Aspirin use in advanced uncontrolled glaucoma
Bell NP; Orengo-Nania S; Pietz K; Gross RL
Journal of Glaucoma 2004; 13: 365-370 (IGR: 6-3)


10626 Acute effects of sildenafil on Humphrey visual field and intraocular pressure
Ermis SS; Inan UU; Samli M; Ozturk F
International Ophthalmology 2004; 25: 69-72 (IGR: 6-2)


10752 Statins and other cholesterol-lowering medications and the presence of glaucoma
McGwin G Jr; McNeal S; Owsley C; Girkin C; Epstein D; Lee PP
Archives of Ophthalmology 2004; 122: 822-6 (IGR: 6-2)


10368 Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination
Magacho L; Lima FE; Costa ML; Fayad FA; Guimaraes NL; Avila MP
Current Eye Research 2004; 28: 189-193 (IGR: 6-1)


9680 The dual role of dexamethasone on anti-inflammation and outflow resistance demonstrated in cultured human trabecular meshwork cells
Leung YF; Tam PO; Lee WS; Lam DS; Yam HF; Fan BJ; Tham CC; Chua JK; Pang CP
Molecular Vision 2003; 9: 425-439 (IGR: 5-3)


9830 Antioxidant intake and primary open-angle glaucoma: a prospective study
Kang JH; Pasquale LR; Willett W; Rosner B; Egan KM; Faberowski N; Hankinson SE
American Journal of Epidemiology 2003; 158: 337-346 (IGR: 5-3)


9949 AL-2512, a novel corticosteroid: preclinical assessment of anti-inflammatory and ocular hypertensive effects
Bhattacherjee P; Mukhopadhyay P; Paterson CA; Graff G; Gamache DA; Yanni JM
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 353-360 (IGR: 5-3)


9951 Ocular dynamics of systemic aqueous extracts of Xylopia aethiopica (African guinea pepper) seeds on visually active volunteers
Igwe SA; Afonne JC; Ghasi SI
Journal Ethnopharmacology 2003; 86: 139-142 (IGR: 5-3)


9950 Effects of Solanum melongena (garden egg) on some visual functions of visually active Igbos of Nigeria
Igwe SA; Akunyili DN; Ogbogu C
Journal Ethnopharmacology 2003; 86: 135-138 (IGR: 5-3)


8230 Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis
Bui Quoc E; Bodaghi B; Adam R; Burtin T; Cassoux N; Dreifuss S; Fardeau C; LeHoang P
Journal Français d'Ophtalmologie 2002; 25: 1048-1056 (IGR: 4-3)


8058 The effect of ipratropium bromide on intraocular pressure in patients with chronic obstructive pulmonary disease: an open-label study
Polatli M; Dayanir V; Polatli O; Ozkan S; Cildag O
Current Therapeutic Research - Clinical and Experimental 2002; 63: 380-387 (IGR: 4-3)


3514 Benzodiazepines and benzodiazepine-like anxiolytics and hypnotics: the implausible contraindication of closed angle glaucoma
Fritze J; Schneider B; Weber B
Nervenarzt 2002; 73: 50-53 (IGR: 4-2)


3596 Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection
Moshfeghi DM; Lowder CY; Roth DB; Kaiser PK
American Journal of Ophthalmology 2002; 134: 132-134 (IGR: 4-2)


18329 Acute effects of sildenafil citrate (Viagra®) on intraocular pressure in open-angle glaucoma
Grunwald JE; Jacob SS; Siu K; Piltz J; Dupont J
American Journal of Ophthalmology 2001; 132: 872-874 (IGR: 3-3)


18328 The endocannabinoid nervous system: unique opportunities for therapeutic intervention
Porter AC; Felder CC
Pharmacology and Therapeutics 2001; 90: 45-60 (IGR: 3-3)


18327 Effect of ketanserin administration on intraocular pressure
Tekat D; Güler C; Kemal Arici M; Topalkara A; Erdöl H
Ophthalmologica 2001; 215: 419-423 (IGR: 3-3)


6518 Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751
Arimura A; Yasui K; Kishino J; Asanuma F; Hasegawa H; Kakudo S; Ohtani M; Arita H
Journal of Pharmacology and Experimental Therapeutics 2001; 298: 411-419 (IGR: 3-2)


6519 Effects of traditional Sino-Japanese herbal medicines on aqueous flare elevation after small-incision cataract surgery
Ikeda N; Hayasaka S; Nagaki Y; Hayasaka Y; Kadoi C; Matsumoto M
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 59-65 (IGR: 3-2)


15808 Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients
Duh MS; Walker AM; Lindmark B; Laties AM
Annals of Allergy Asthma and Immunology 2000; 85: 356-361 (IGR: 2-3)


16001 Glutamate in experimental acute elevated intraocular pressure models of rabbits
Wang P; Jiang Y; Huang P
Chinese Journal of Ophthalmology 2000; 36: 378 (IGR: 2-3)


6217 Effect of oral Losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects
Costagliola C; Verolino M; De Rosa ML; Iaccarino G; Ciancaglini M; Mastropasqua L
Experimental Eye Research 2000; 71: 167-171 (IGR: 2-2)


6218 Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma
Shah GB; Sharma S; Mehta AA; Goyal RK
Journal of Cardiovascular Pharmacology 2000; 36: 169-175 (IGR: 2-2)


6219 No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra)
Yajima T; Yajima Y; Koppiker N; Grunwald JE; Laties AM
American Journal of Ophthalmology 2000; 129: 675-676 (IGR: 2-2)


5841 Use of polyunsatured fatty acids in the treatment of glaucomatous optic neuropathy (GON)
Caramazza N; Damele M; Parente G; Alessandrini A; Cellini M
Annali di Ottalmologia e Clinica Oculistica 1999; 125:329-338 (IGR: 2-1)


5842 Taxane induced glaucoma (letter).
Del Pilar Bernal M; Loftfield K; Nussdorf JD
Lancet 2000; 355: 577 (IGR: 2-1)


5843 Sildenafil (Viagra) associated anterior ischemic optic neuropathy(letter).
Egan R; Pomeranz H
Archives of Ophthalmology 2000; 118: 291-2 (IGR: 2-1)


5844 Taxane induced glaucoma (letter).
Fabre-Guillevain E; Tchen N; Anibali-Charplat M; Calluaud L; Ravaud A
Lancet 1999; 354: 1181-1182 (IGR: 2-1)


Issue 20-3

Select Issue


advertisement

WGC-2021